Embed Size (px)
Citation preview
CURRICULUM VITAE
I. PERSONAL DATA
Name: Andrew D. Michaels, M.D., M.A.S., F.A.C.C., F.A.H.A.
Birth Place: Ann Arbor, MI
Citizenship: United States of America
Personal: Married with five children
Contact: 2773 Harris Street, Suite A, Eureka, CA 95503
Tel: 707-442-1182; Fax: 707-442-1635; Email: [email protected]
II. EDUCATION
A. Baccalaureate Degree
1986-1990 B.A., Harvard College, Magna Cum Laude in History and Science
B. Advanced Degree
1990-1994 M.D., University of California, San Francisco, School of Medicine
2004-2006 M.A.S. (Master’s in Advanced Studies Degree Program in Clinical
Research), UCSF Department of Epidemiology and Biostatistics
C. Resident/Fellowship Training
1994-1996 Internship and Residency, Clinical Investigator Pathway
University of California, San Francisco, Internal Medicine
1996-1998 Clinical Cardiology Fellowship
University of California, San Francisco, Division of Cardiology
1998-2000 Interventional Cardiology and Clinical Trial Research Fellowships
University of California, San Francisco, Division of Cardiology
III. BOARD CERTIFICATIONS
1997 Internal Medicine Diplomat, American Board of Internal Medicine (Score in
highest decile; Recertified 5/15/2007; Exp. 12/31/2017)
2000 Cardiovascular Disease Diplomat, ABIM Subspecialty Board (Score in highest
decile; Recertified 4/26/2010; Exp. 12/31/2020)
August 16, 2013 2
2003 Interventional Cardiology Diplomat, ABIM Subspecialty Board (Score in
highest decile; Recertified 9/3/2013; Exp. 12/31/2023)
IV. CURRENT LICENSES/CERTIFICATIONS
1995-pres California Medical License A54428 (Exp. 6/30/2015)
1995-pres Drug Enforcement Administration Registration BM4613229 (Exp.
1/31/2016)
1996-pres Advanced Cardiac Life Support (Exp. 8/2015)
1996-pres Basic Life Support (Exp. 8/2015)
1997-pres California Fluoroscopy Supervisor & Operator Permit RHC 144236 (Exp.
10/31/2014)
2012-pres Oregon Medical License MD15972 (Exp. 12/31/2015)
V. PROFESSIONAL EXPERIENCE
A. Full Time Positions
2000-2006 Assistant Professor of Medicine
University of California, San Francisco, Division of Cardiology
2001-2006 Co-Director, Adult Cardiac Catheterization Laboratory
University of California, San Francisco, Division of Cardiology
2006-2010 Associate Professor of Medicine, Award of Clinical-Scholar Tenure in 2009
Director, Cardiac Catheterization Laboratory and Interventional Cardiology,
University of Utah, Division of Cardiology
2008-2010 Adjunct Associate Professor of Bioengineering, University of Utah
2010-pres Humboldt Medical Specialists, Interventional Cardiologist, Eureka, CA
Chief, Cardiology, St. Joseph Hospital, Eureka, CA
Director, Cardiac Catheterization Laboratory, St. Joseph Hospital, Eureka, CA
2013-pres Clinical Assistant Professor of Internal Medicine
Western University of Health Sciences, Pomona, CA
B. Editorial Experience
2000-present Ad hoc reviewer, American Journal of Cardiology
2000-present Ad hoc reviewer, American Journal of Medicine
2000-present Ad hoc reviewer, Journal of the American College of Cardiology
2000-present Ad hoc reviewer, Journal of Gerontology
August 16, 2013 3
2001-present Ad hoc reviewer, Catheterization and Cardiovascular Interventions
2002-present Ad hoc reviewer, Annals of Internal Medicine
2002-present Ad hoc reviewer, Circulation
2002-present Ad hoc reviewer, Lancet
2003-present Ad hoc reviewer, Journal of Cardiac Failure
2005-present Ad hoc reviewer, American Heart Journal
2005-present Ad hoc reviewer, Journal of Geriatric Cardiology
2005-present Ad hoc reviewer, Journal of Internal Medicine
2006-present Ad hoc reviewer, Journal of Hypertension
2008-present Ad hoc reviewer, Congenital Heart Disease
2008-present Ad hoc reviewer, Echocardiography
2008-present Ad hoc reviewer, Circulation-Cardiovascular Interventions
2008-present Ad hoc reviewer, European Journal of Heart Failure
2009-present Ad hoc reviewer, Acta Cardiologica
2010-present Ad hoc reviewer, Chinese Journal of Physiology
C. Research Competitive Awards
Past Grants
1998-1999 Angiogenic Effects of Heparin and Adenosine in Refractory Angina
Direct Costs: $35,000; Total Costs: $35,000
American College of Cardiology/Merck Cardiology Research Fellowship
Role: Principal Investigator
1999-2000 Angiogenic Effects of Heparin and Adenosine in Refractory Angina
National Institutes of Health (NIH) National Research Service Award (deferred)
Role: Principal Investigator
1999-2000 Angiogenic Effects of Heparin and Adenosine in Refractory Angina
American Heart Association Postdoctoral Fellowship Award
Direct Costs: $31,000; Total Costs: $31,000
Role: Principal Investigator
2001-2002 UCSF School of Medicine Research Evaluation & Allocation Committee
(REAC) Award
Direct Costs: $25,000; Total Costs: $25,000
Role: Principal Investigator
2001-2003 Left Ventricular and Coronary Hemodynamics with External Counterpulsation
Direct Costs: $120,000; Total Costs: $120,000
August 16, 2013 4
American Heart Association Beginning Grant-in-Aid Award, Western States
Affiliate
Role: Principal Investigator
2001-2003 GlaxoSmithKline Development Partners’ Junior Faculty Award
Direct Costs: $100,000; Total Costs: $100,000
Role: Principal Investigator
2004-2006 Evaluation of Idorotenone, A SPECT Perfusion Tracer (PI HF VanBrocklin; 1
R01EB000482-01)
Direct Costs: $282,688; Total Costs: $353,360
National Institutes of Health R01
Role: Co-Investigator
2004-2008 Dynamic Cardiac SPECT Imaging (PI G Gullberg; 1 R01EB001970-10A2)
Direct Costs: $385,738; Total Costs: $482,173
National Institutes of Health R01
Role: Co-Investigator
2004-2009 External Counterpulsation in Acute Coronary Syndrome
Direct Costs: $563,750; Total Costs: $608,850
National Institutes of Health Mentored Patient-Oriented Research Career
Development Award (K23 RR018319-01)
Role: Principal Investigator
Grant Reviewer
2009 NIH RC1 Challenge Grant Reviewer
D. Multi-Center Research Experience
1999-2000 Phase II, Multicenter, Double-Blind, Placebo-Controlled, Dose Finding Study
for Safety, Pharmacokinetics and Efficacy of rFGF-2 in Subjects with CAD
(Chiron).
Role: Site Co-Investigator
1999-2000 FFR or RFVR Evaluation of Coronary Artery Stenosis Versus Thallium
(FORECAST; Radi Medical Systems).
Role: Site Co-Investigator
1999-2000 Fractional Flow Reserve and Ultrasound Indices for Objective Narrowing
Assessment (FUSION; Radi Medical Systems).
Role: Site Co-Investigator
1999-2000 Phase III Prevention of Restenosis with Tranilast and Its Outcomes: A Placebo-
Controlled Trial (PRESTO; GlaxoSmithKline).
Role: Site Co-Investigator
2000-2001 Integrilin and TNK in Acute Myocardial Infarction (INTEGRITI; Cor
Therapeutics).
Role: Site Co-Investigator
August 16, 2013 5
2000-2001 Randomized, Multicenter, Double-Blind, Abciximab-Controlled Study to
Evaluate the Efficacy of Tirofiban and Abciximab in Patients Undergoing
Percutaneous Coronary Intervention with Intracoronary Stent Placement
(TARGET; Merck).
Role: Site Co-Investigator
2000-2001 Randomized, Parallel-Groups, Dose-Selection Study of MRE0470 in Patients
Following Coronary Angiography (MedCo).
Role: Site Principal Investigator
2000-2006 International Enhanced External Counterpulsation (EECP) Patient Registry
(IEPR) Working Group (Vasomedical).
Role: Member (2000-04); Medical Director (2004-06)
2002 Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events,
Part 2 (REPLACE-2; Medicines Co).
Role: Site Principal Investigator
2002-2003 Multicenter Pilot Trial of the Effects of EECP on Scintigraphic Extent of
Myocardial Ischemia (Vasomedical).
Role: Site Principal Investigator
2002-2006 Multicenter Trial of the Effects of EECP on Heart Rate Variability
(Vasomedical).
Role: Site Principal Investigator
2008-2009 Protocol CY 1124. A Phase II Open-Label Study to Investigate the Effects of
CK-1827452 Injection on Ventricular Performance, Myocardial Oxygen
Consumption, and Myocardial Efficiency in Patients with Heart Failure and Left
Ventricular Systolic Dysfunction (Cytokinetics, South San Francisco, CA).
Direct Costs: $133,764; Total Costs: $154,348; University of Utah
Role: Site Principal Investigator
E. Single-Center Investigator-Initiated Industry Sponsored Studies
2001-2003 Coronary Hemodynamic Effects of Nesiritide (Scios, Inc., Fremont, CA).
Direct Costs: $60,434; Total Costs: $77,479; UCSF
Role: Principal Investigator
2003-2005 Coronary Hemodynamic Effects of Levosimendan (Abbott Laboratories, Abbott
Park, IL).
Direct Costs: $67,642; Total Costs: $82,523; UCSF
Role: Principal Investigator
2003-2005 Hemodynamic Effects of Nesiritide in Pulmonary Hypertension (Scios, Inc.,
Fremont, CA).
Direct Costs: $116,870; Total Costs: $142,582; UCSF
Role: Principal Investigator
2003-2010 Myocardial Hemodynamics and Electrophonocardiography (Inovise Medical
Inc., Portland, OR).
August 16, 2013 6
Direct Costs: $30,000; Total Costs: $30,000; UCSF
Direct Costs: $20,000; Total Costs: $20,000; University of Utah
Role: Principal Investigator
2003-2006 Effects of Aggrenox on Myocardial Blood Flow (Boerhinger Ingelheim,
Germany).
Direct Costs: $102,459; Total Costs: $125,000; UCSF
Role: Principal Investigator
2004-2006 X-Ray Coronary Imaging: Rotational Acquisition and StentBoost (Philips
Medical Systems, Bothell, WA).
Direct Costs: $20,000; Total Costs: $20,000; UCSF
Role: Principal Investigator
2006-2007 Hemodynamic Effects of Nesiritide in Diastolic Heart Failure (Scios, Inc.,
Fremont, CA).
Direct Costs: $98,471; Total Costs: $111,324; University of Utah
Role: Principal Investigator
2006-2009 Hemodynamic Effects of Levosimendan in Diastolic Heart Failure (Abbott
Laboratories, Abbott Park, IL).
Direct Costs: $139,520; Total Costs: $154,466; University of Utah
Role: Principal Investigator
2011-2012 A Phase 2 Open Study of the Effects of CXL-1020 on Right Heart
Hemodynamics, Left Ventricular Pressure-Volume Relationships, Isovolumic
Relaxation, and Maximal Ventricular Power in Patients with Systolic or
Diastolic Heart Failure (Cardioxyl Pharmaceuticals, Chapel Hill, NC).
Direct Costs: $126,595; Total Costs: $137,623; St. Joseph Hospital, Eureka, CA
Role: Principal Investigator
F. Industry Sponsored Event Review Committees
2002-2003 ACCULINK for Revascularization of Carotids in High-Risk Patients
(ARCHeR) (Sponsor: Guidant, Corp., St. Paul, MN).
2009-2010 Phase 3 AF37702 Injection (Hematide) (Sponsor: Affymax, Inc., Palo Alto, CA;
ERC Coordinating Center: Axio, Seattle, WA).
VI. SCHOLASTIC HONORS
1983-1986 Andover H.S. (Bloomfield Hills, MI) Valedictorian and 2 Varsity sports
1986-1990 John Harvard Honorary Scholarships, Harvard College
1991 Dean's Summer Research Fellowship, UCSF
1992 Dean's Prize in Student Research, UCSF
1993 Alpha Omega Alpha Honor Medical Member Society, UCSF
August 16, 2013 7
2002 Clinical Research Junior Faculty Award, 2nd
Place, 8th
Annual AstraZeneca
Cardiovascular Young Investigators’ Forum
2002 Samuel A. Levine Young Clinical Investigator Finalist Award, American Heart
Association Scientific Sessions, Council on Clinical Cardiology
2009 Conference Poster Competition Winner, International Society for Computerized
Electrocardiography Scientific Sessions
VII. ADMINISTRATIVE EXPERIENCE
2001-2006 Co-Director, Adult Cardiac Catheterization Laboratory, University of
California, San Francisco, CA
2006-2010 Director, Adult Cardiac Catheterization Laboratory and Interventional
Cardiology, University of Utah, Salt Lake City, UT
2010-pres Chief, Cardiology & Director, Cardiac Catheterization Laboratory, St. Joseph
Hospital, Eureka, CA
VIII. PROFESSIONAL COMMUNITY ACTIVITIES
1993-1995 Physician assistant, Diabetes Camp, Kings Canyon National Park
2004-2009 Volunteer instructor for cardiac catheterization physicians in China and
Vietnam
2004-2009 Articles and clinical cases featured with interviews in The Chronicle,
www.theheart.org, www.medscape.com, Reuters Health, NPR, and KSL TV.
2011-2012 Public service announcements for NBC KIEM News Channel 3 and radio in
Eureka, CA.
2012 Community Health Forum. Heart and Blood Vessel Health. Eureka, CA, June
14, 2012.
2012-pres Team STEPPS Trainer at St. Joseph Hospital, Eureka, CA
2012-pres Physician Well-Being Committee, Humboldt-Del Norte County Medical
Society
2013 Local NBC KIEM news television story on cardiology patient (August 16,
2013).
IX. HOSPITAL ACTIVITIES
A. Hospital Committees
2001-2006 Practice Guideline Committee for Acute Coronary Syndromes, UCSF
2001-2006 Emergency and Interventional STEMI Management, UCSF
August 16, 2013 8
2003-2006 Member, UCSF Adult Cardiac Catheterization Equipment Upgrade Planning
Committee
2003-2006 Annual Report of the UCSF Interventional Cardiology Division to the Clinical
Performance Improvement Committee
2006-2008 Chair, VA Task Force on Reperfusion Therapy for STEMI Patients
2006-2010 Chair, University of Utah Committee on Reperfusion Therapy for STEMI
Patients
2007-2010 Member, University of Utah School of Medicine, Resident Hearing Committee
2008-2010 Team Member, University of Utah Hospital and Clinics, Exceptional Patient
Experience Committee
2011-pres Quality Steering Committee, St. Joseph Hospital, Eureka, CA
2011-pres Primary PCI Committee, St. Joseph Hospital, Eureka, CA
B. Hospital Community
2003-2006 Ad Hoc UCSF Faculty Search Committee, Pediatric Interventional Cardiology
2008-2009 Ad Hoc University of Utah Faculty Search Committee, VA Cardiology Section
Chief
X. MEMBERSHIP IN PROFESSIONAL SOCIETIES
1996-pres American College of Cardiology, Fellow
1999-pres American Heart Association, Council on Clinical Cardiology, Fellow
Committee Member, Acute Cardiac Care Committee (2005-2007)
Vice-Chair, Acute Cardiac Care Committee (2007-2009)
Chair, Acute Cardiac Care and General Cardiology Committee (2009-2011)
Member, Leadership Committee (2009-2011)
XI. TEACHING RESPONSIBILITIES/ASSIGNMENTS
A. Courses Taught
2000-2001 Cardiovascular Discipline Chief, UCSF Introduction to Clinical Medicine
(ICM), Medicine 132A, 2nd
-year medical students, 5 lectures/yr, class size 150
2001-2006 Lecturer, UCSF Cardiovascular Organs Block, 1st-year medical students, 6
lectures/yr, class size 150
2002-2005 Small group leader, UCSF Cardiovascular Organs Block, Cardiac Pathology
Laboratory, 1st-year medical students, 1 session/yr, class size 150
2005-2006 Lecturer, UCSF Mechanisms of Disease, 4th
-year medical students, 1 lecture/yr,
class size 150
2006-2010 Lecturer, University of Utah Cardiology, 2nd-year medical students, 1
lecture/yr, class size 100
August 16, 2013 9
B. Students/Trainees Supervised
Pre-doctoral Students Supervised or Mentored:
Dates Name Program or
School
Role Current
Position
2001 Maggie V. Lakshmi Mysore University
India
Supervised
research project
Resident, St
Louis University
2003-2004 Mark V. Jordan, MD Univ of Pretoria,
South Africa
Supervised
research
projects
Resident, Case
Western Reserve
2003-2004 Atul Gera Columbia Univ Supervised
summer
research
UC Davis Med
Student
2003-2004 Keane Lee UCSF Med
Student
Supervised
research project
UCSF Medicine
Resident
2003-2006 Kalpesh T. Vakharia UCSF Med
Student
Supervised
research year
UCSF Medical
Student
2004-2006 Mia Shapiro Clinical Research,
UCSF
Research
assistant
Boston
University
Medical Student
2005-2006 Brian Moyers UCSF Med
Student
Supervised
research project
UCSF Medical
Student
2007-2008 Spencer Clegg Univ of Utah
Engineering
Project
supervisor
Univ of Utah
Engineering
undergrad
2008-2010 David Sutherland Univ of Utah Med
Student
Supervised
research project
Univ of Utah
Medical Student
2013 Kraig Wasik Western University Cardiology
rotation
Western
University
medical student
Post-doctoral Fellows and Residents Directly Supervised or Mentored:
Dates Name Program or
School
Role Current Position
2002 Kent Dauterman,
MD
UCSF
Interventional
Cardiology Fellow
Supervised
research
projects
Cardiology
Practice,
Medford, Oregon
2003-2006 Mateen Akhtar, MD UCSF Medicine
Resident
Supervised
research
projects
UCSF Resident
2003-2005 Joshua Vessey, MD UCSF Medicine
Resident
Supervised
research
Cardiology
Fellow, Cornell
August 16, 2013 10
projects
2003-2006 Gregory Marcus,
MD
UCSF Cardiology
Fellow
Supervised
research
projects
UCSF Cardiology
Attending
2004 Nguyen Dang Tuan,
MD
Heart Institute of
Ho Chi Minh City
Supervised
preceptorship
Interventionalist,
Heart Institute of
Ho Chi Minh City
2004-2005 Jacob Mishell, MD UCSF
Interventional
Cardiology Fellow
Supervised
research
projects
Cardiology
Practice, Kaiser
San Francisco
2004-2005 Michael Kostal, MD UCSF Medicine
Resident
Supervised
research project
UCSF Chief
Med Resident
2004-2006 Ian Harris, MD UCSF Cardiology
Fellow
Supervised
research project
UCSF Cardiology
Fellow
2004-2006 Mohan
Viswanathan, MD
UCSF Cardiology
Fellow
Supervised
research project
UCSF Cardiology
Fellow
2005-2006 Kiran Khush, MD UCSF Cardiology
Fellow
Supervised
research project
UCSF Cardiology
Attending
2005-2006 Sanjiv Shah, MD UCSF Cardiology
Fellow
Supervised
research project
Northwestern
Cardiology
Attending
2006-2008 Douglas Kosmicki,
MD
Univ of Utah
Cardiology Fellow
Supervised
research project
Cardiology
Practice,
Nebraska Heart
2006-2008 Saurabh Gupta, MD Univ of Utah
Cardiology Fellow
Supervised
research project
Oregon Health
Sciences, Asst
Professor
2006-2009 Stilianos
Efstratiadis, MD
Univ of Utah
Cardiology Fellow
Supervised
research project
Univ of Utah
Cardiology
Fellow
2006-2009 Jeetendra Patel, MD Univ of Utah
Cardiology Fellow
Supervised
research project
Univ of Utah
Cardiology
Fellow
2007-2009 Kevin Rogers, MD Univ of Utah
Cardiology Fellow
Supervised
research project
Univ of Utah
Cardiology
Fellow
2007-2010 Shadi Karabsheh,
MD
University of Utah
Research Assistant
Supervised
research project
Clinical Research
Assistant
2009-2010 Bhava Reddy, MD Univ of Utah
Cardiology Fellow
Supervised
research project
Univ of Utah
Cardiology
Fellow
PhD Dissertation Committee Member:
Dates Name Program or
School
Role Current Position
August 16, 2013 11
2003-2007 Eunyoung Lee, RN,
ANP
UCSF, School of
Nursing
PhD
Dissertation
Committee
Nurse, Tucson
Medical Center
2006-2007 Shibaji Shome, BE Univ of Utah, Dept
of Bioengineering
Dissertation
Committee
Scientist, Boston
Scientific
2008-2010 Kedar Aras, BS Univ of Utah, Dept
of Bioengineering
Dissertation
Committee
Postdoctoral
Student, Univ of
Utah
Foreign Exchange Physicians Supervised:
Dates Name Sponsoring Institution Role
July-Oct
2004
Nguyen Dang Tuan,
MD
Heart Institute of Ho Chi
Minh City, Vietnam
Interventional cardiology
fellow
Oct 2006-
April 2007
Marian Branny, MD Prague, Czech Republic Private practice cardiologist
July-August
2008
Anna Amosova, MD Perm State Clinical
Hospital, Russia
Internal medicine resident
Post-doctoral Trainee Young Investigator Awards:
Sanjiv Shah, MD Finalist, Laennec Young Clinician Award, American Heart
Association, 2005
Sanjiv Shah, MD American Association of Cardiologists of Indian Origin
(AACIO) Young Investigator Award, 2005
Eunyoung Lee, RN, PhD Recipient, Martha N. Hill New Investigator Award in
Cardiovascular Nursing, American Heart Association, 2008
Eunyoung Lee, RN, PhD Finalist, Jos Willems Young Investigator, International
Society for Computerized Electrocardiology, 2008
C. Course and Curriculum Development
2000-2002 Clinical Cardiology Syllabus, Cardiovascular Organs Block for 1st year medical
students.
2001 Michaels AD, Frances C. Saint-Frances Guide to Cardiology, Philadelphia:
Lippincott Williams & Wilkins, 2001. This textbook is used by medical
students throughout the US studying clinical cardiology.
2001-2006 UCSF Cardiology Multimedia Library. I developed this online resource for
UCSF medical students to supplement the curriculum for learning clinical
cardiology.
August 16, 2013 12
D. Educational Lectures
Medical School Lectures:
1. UCSF Medical School, Introduction to Clinical Medicine 132, September 18, 2000;
September 17, 2001: “Cardiac History.”
2. UCSF Medical School, Introduction to Clinical Medicine 132, September 21, 2000;
September 21, 2001: “Cardiac Physical Examination.”
3. UCSF Medical School, Introduction to Clinical Medicine 132, September 25, 2000;
September 24, 2001: “Ischemic Heart Disease.”
4. UCSF Medical School, Introduction to Clinical Medicine 132, October 2, 2000; September 28,
2001: “Valvular Heart Disease: Pathophysiology, Clinical Manifestations, Management.”
5. UCSF Medical School, Introduction to Clinical Medicine 132, October 2, 2000; October 1,
2001: “Inflammatory Diseases of Valves.”
6. UCSF Medical School, First-Year Organ Block, November 6, 2001; November 5, 2002;
November 4, 2003; November 12, 2004; November 8, 2005: “Valvular Heart Disease:
Pathophysiology, Clinical Manifestations, Management.”
7. UCSF Medical School, First-Year Organ Block, November 7, 2001; November 8, 2002;
November 14, 2003; November 15, 2004; November 10, 2005: “Cardiac Physical
Examination.”
8. UCSF Medical School, First-Year Organ Block, November 7, 2001; November 6, 2002;
November 6, 2003; November 12, 2004; November 9, 2005: “Inflammatory Valve Disease.”
9. UCSF Medical School, First-Year Organ Block, November 21, 2001; November 21, 2002;
November 26, 2003; December 1, 2004: “Ischemic Heart Disease.”
10. UCSF Medical School, Second-Year Medical Class, January 23, 2002; January 28, 2004;
January 26, 2005; January 25, 2006: “USMLE-I Board Review for Cardiology.”
11. UCSF Medical School, First-Year Organ Block, December 4, 2002; December 9, 2003;
December 9, 2004; December 8, 2005: “Pericardial Disease.”
12. UCSF Medical School, Fourth-Year Mechanisms of Disease, May 2, 2005: “Chest Pain
Evaluation.”
13. UCSF Medical School, First-Year Organ Block, November 29 and 30, 2005: “Acute
Myocardial Infarction.”
14. University of Utah Medical School, Second-Year Medical Class, December 13, 2006;
December 4, 2007; December 1, 2008; December 7, 2009: "Acute Myocardial Infarction."
15. University of Utah Medical School, Pre-Clinical MD/PhD Students, December 19, 2006:
"Interventional Cardiology."
16. University of Utah Medical School, Second-Year Medical Class, December 10, 2008;
December 2, 2009: "Pericardial Disease."
School of Bioengineering Lectures:
August 16, 2013 13
1. University of Utah School of Bioengineering Seminar, April 4, 2008: “Acoustic
Cardiographic Assessment of Hemodynamics, Ischemia, and Arrythmias.”
Internal Medicine Housestaff Lectures:
1. UCSF Internal Medicine Housestaff Conference, August 20, 1998 (San Francisco General
Hospital); August 21, 1998 (Veterans’ Administration Medical Center at San Francisco);
September 20, 1998 (UCSF Medical Center): “Refractory Angina: Novel Options.”
2. Monthly 45-minute lecture to housestaff on Moffitt Coronary Care Unit rotation, 2000-2004:
“Introduction to Cardiac Catheterization.”
3. University of Utah, Internal Medicine Housestaff Conference, December 10, 2007;
September 26, 2008; July 30, 2009 (Intermountain Medical Center), December 13, 2007;
September 18, 2008; July 20, 2009 (University of Utah), January 2, 2008; September 11,
2008; July 23, 2009 (George E. Wahlen Department of Veterans Affairs Medical Center):
“Valvular Heart Disease: Pathophysiology, Clinical Manifestations, Management.”
Cardiology Fellow Teaching: 2000-2006 Moffitt Adult Cardiac Catheterization Laboratory attending, inpatient cardiology
attending, and Cardiology Faculty Practice outpatient clinic attending.
2006-2010 University of Utah Cardiac Catheterization Laboratory attending, inpatient
cardiology attending, and Interventional Cardiology outpatient clinic attending.
Cardiology Fellow Lectures: 1. UCSF Cardiology Fellow Course, August 3, 1999; July 20, 2000; July 18, 2001; August 13,
2002; July 9, 2003; July 14, 2004: “Intra-aortic Balloon Pump Hemodynamics and
Troubleshooting.”
2. UCSF Cardiology Fellow Course, July 2, 2003; July 7, 2004, July 13, 2005: “Immediate
Reperfusion Therapy in Acute Myocardial Infarction.”
3. University of Utah, July 11, 2006; July 11, 2007; July 16, 2008; July 27, 2009: “Introduction
to Coronary Angiography.”
4. University of Utah, July 18, 2006, November 19, 2008, November 4, 2009: "Equalization of
Diastolic Pressures: What is the Diagnosis?"
5. University of Utah, December 13, 2006: "Coronary and Myocardial Hemodynamics: Beyond
the Basics."
6. University of Utah, July 18, 2007; August 27, 2008; July 30, 2009: “Intra-Aortic Balloon
Pump.”
7. University of Utah, August 1, 2007: “Immediate Reperfusion Therapy in Acute Myocardial
Infarction.”
August 16, 2013 14
8. University of Utah, July 7, 2008; July 8, 2009: “Evidence-Based Acute STEMI
Management.”
9. University of Utah, August 6, 2008; August 24, 2009: “Temporary Pacing, Myocardial
Biopsy, and Pericardiocentesis.”
10. University of Utah, January 14, 2009: “Mitral and Aortic Valvuloplasty.”
11. University of Utah, June 3, 2009: “Percutaneous Ventricular Support Devices.”
12. University of Utah, September 10, 2009: “Assessment of ST Changes for Ischemia/Injury.”
Emergency Medical Technician (EMT) Lectures: 1. College of the Redwoods EMT Course, McKinleyville, CA, March 10, 2012: “Acute STEMI
Management.”
Bibliography
I. ORIGINAL PEER-REVIEWED PUBLICATIONS
1. Barron HV, Michaels AD, Maynard C, Every NR. Use of angiotensin-converting enzyme
inhibitors at discharge in patients with acute myocardial infarction in the United States: data
from the National Registry of Myocardial Infarction 2. Journal of the American College of
Cardiology 1998; 32: 360-367. PMID: 9708461.
2. Michaels AD, Maynard C, Every NR, Barron HV. Early use of ACE inhibitors in the
treatment of acute myocardial infarction in the United States: experience from the National
Registry of Myocardial Infarction 2. American Journal of Cardiology 1999; 84: 1176-1181.
PMID: 10569326.
3. Barron HV, Sciammarella MG, Lenihan K, Michaels AD, Botvinick EH. Effects of the
repeated administration of adenosine and heparin on myocardial perfusion in patients with
chronic stable angina pectoris. American Journal of Cardiology 2000; 85: 1-7. PMID:
11078227.
4. Michaels AD, Browne A, Varghese P, Chou TM. Intracoronary measurement of pulsus
alternans. Catheterization and Cardiovascular Interventions 2000; 51: 335-338. PMID:
11066122.
5. Michaels AD, Kennard ED, Kelsey S, Holubkov R, Ozlem S, Spence S, Chou TM. Does
higher diastolic augmentation predict clinical benefit from enhanced external
counterpulsation (EECP)?: data from the International Enhanced External Counterpulsation
Patient Registry. Clinical Cardiology 2001; 24: 453-458. PMID: 11403506.
6. Michaels AD, Ports TA. Use of a percutaneous arterial suture device (Perclose) in patients
undergoing percutaneous balloon aortic valvuloplasty. Catheterization and Cardiovascular
Interventions 2001; 53: 445-447. PMID: 11514991.
7. Gibson CM, Dotani I, Murphy SA, Marble SJ, Dauterman K, Michaels AD, Dodge JT Jr.
Correlates of coronary blood flow before and after percutaneous coronary intervention and
August 16, 2013 15
their relationship to angiographic and clinical outcomes in the RESTORE trial. American
Heart Journal 2002; 144: 130-135. PMID: 12094199.
8. Michaels AD, Appleby M, Dauterman K, Ports TA, Chou TM, Gibson CM. Pretreatment
with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft
lesions: results of the randomized, controlled vasodilator prevention of no-reflow (VAPOR)
trial. Journal of Invasive Cardiology 2002; 14: 299-302. PMID: 12042618.
9. Lakshmi MV, Kennard ED, Kelsey SF, Holubkov R, Michaels AD. Relation of the pattern
of diastolic augmentation during a course of enhanced external counterpulsation (EECP) to
clinical benefit [from the International EECP Patient Registry (IEPR)]. American Journal of
Cardiology 2002; 89: 1303-1305. PMID: 12031734.
10. Michaels AD, Accad M, Ports TA, Grossman W. Left ventricular systolic unloading and
augmentation of intracoronary pressure and Doppler flow during enhanced external
counterpulsation (EECP). Circulation 2002; 106: 1237-1242. PMID: 12208799.
11. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, Dauterman KW, Michaels A, Barron
HV, Antman EM; TIMI Study Group. Methodologic and clinical validation of the TIMI
myocardial perfusion grade in acute myocardial infarction. Journal of Thrombosis and
Thrombolysis 2002; 14: 233-237. PMID: 12913404.
12. Linnemeier G, Michaels AD, Soran O, Kennard E. Enhanced external counterpulsation in
the management of angina in the elderly. American Journal of Geriatric Cardiology 2003;
12: 90-96. PMID: 12624578.
13. Michaels AD, Klein A, Madden JA, Chatterjee K. Effects of intravenous nesiritide on human
coronary vasomotor regulation and myocardial oxygen uptake. Circulation 2003; 107: 2697-
2701. PMID: 12742984.
14. Michaels AD, Linnemeier G, Soran O, Kennard ED. Two-year outcomes after enhanced
external counterpulsation for stable angina pectoris [from the International EECP Patient
Registry (IEPR)]. American Journal of Cardiology 2004; 93: 461-464. PMID: 14969624.
15. Marcus GM, Michaels AD, DeMarco T, McCulloch CE, Chatterjee K. Usefulness of the
third heart sound in predicting an elevated level of B-type natriuretic peptide. American
Journal of Cardiology 2004; 93: 1312-1313. PMID: 15135714.
16. Marcus G, Gerber IL, McKeown B, Vessey J, Jordan MV, Huddleston M, McCulloch CE,
Foster E, Chatterjee K, Michaels AD. Association between phonocardiographic third and
fourth heart sounds and objective measures of left ventricular function. JAMA 2005; 293:
2238-2244. PMID: 15886379.
17. Michaels AD, Barsness GW, Soran O, Kelsey SF, Kennard ED, Hui JC, Lawson WE, for the
International EECP Patient Registry Investigators. Frequency and efficacy of repeat
enhanced external counterpulsation for stable angina pectoris (from the International EECP
Patient Registry [IEPR]). American Journal of Cardiology 2005; 95: 394-397. PMID:
15670552.
18. Michaels AD, McKeown B, Kostal M, Vakharia KT, Jordan MV, Gerber IL, Foster E,
Chatterjee K. Effects of intravenous levosimendan on human coronary vasomotor regulation,
left ventricular wall stress, and myocardial oxygen uptake. Circulation 2005; 111: 1504-
1509. PMID: 15781741.
August 16, 2013 16
19. Michaels AD, Chatterjee K, De Marco T. Effects of intravenous nesiritide on pulmonary
vascular hemodynamics in pulmonary hypertension. Journal of Cardiac Failure 2005, 11:
425-431. PMID: 16105633.
20. Akhtar M, Vakharia KT, Mishell J, Gera A, Ports TA, Yeghiazarians Y, Michaels AD.
Randomized study of the safety and clinical utility of rotational vs. standard coronary
angiography using a flat-panel detector. Catheterization and Cardiovascular Interventions
2005; 66: 43-49. PMID: 16082684.
21. Michaels AD, Raisinghani A, Soran O, de Lame PA, Lemaire ML, Kligfield P, Conti CR,
Watson DD, Beller G. The effects of enhanced external counterpulsation on myocardial
perfusion in patients with stable angina: a multicenter study. American Heart Journal 2005;
150: 1066-1073. PMID: 16291000.
22. Khush KK, Gerber IL, McKeown B, Marcus G, Vessey J, Foster E, Chatterjee K, Michaels
AD. Obese patients have lower B-type and atrial natriuretic peptide levels compared to the
non-obese. Congestive Heart Failure 2006; 12: 85-90. PMID: 16596042.
23. Klein A, Lee K, Gera A, Ports TA, Michaels AD. Long-term mortality, cause of death, and
temporal trends in complications after percutaneous aortic balloon aortic valvuloplasty for
calcific aortic stenosis. Journal of Interventional Cardiology 2006; 19: 269-275. PMID:
16724971.
24. Marcus G, Vessey J, Jordan MV, Huddleston M, McKeown B, Gerber IL, Foster E,
Chatterjee K, McCulloch CE, Michaels AD. Relationship between accurate auscultation of a
clinically useful third heart sound improves with advancing level of experience. Archives of
Internal Medicine 2006; 166: 617-622. PMID: 16567599.
25. Shah SJ, Marcus GM, Gerber IL, McKeown B, Vessey JC, Jordan MV, Huddleston M,
Foster E, Chatterjee K, Michaels AD. High-sensitivity C-reactive protein and parameters of
left ventricular dysfunction. Journal of Cardiac Failure 2006; 12: 61-65. PMID: 16500582.
26. McCullough PA, Kennard ED, Kelsey SF, Michaels AD. Impact of body mass index on
outcomes of enhanced external counterpulsation therapy. American Heart Journal 2006; 151:
139.e9-139.e13. PMID: 16368306.
27. Harris I, Lee E, Yeghiazarians Y, Drew BJ, Michaels AD. Phonocardiographic timing of
third and fourth heart sounds during acute myocardial infarction. Journal of
Electrocardiology 2006; 39: 305-309. PMID: 16777517.
28. Lawson WE, Hui JCK, Kennard ED, Kelsey SF, Michaels AD, Soran O. Two-year outcomes
of patients with mild angina treated with enhanced external counterpulsation. Clinical
Cardiology 2006; 29: 69-73. PMID: 16506642.
29. Akhtar M, Wu GF, Du ZM, Zheng ZS, Michaels AD. Effect of external counterpulsation on
plasma nitric oxide and endothelin-1 levels. American Journal of Cardiology 2006; 98: 28-
30. PMID: 16784915.
30. Khush KK, De Marco T, Vakharia KT, Harmon CT, Fineman J, Chatterjee K, Michaels AD.
Nesiritide acutely increases pulmonary and systemic levels of nitric oxide and cGMP in
patients with pulmonary hypertension. Journal of Cardiac Failure 2006; 12: 507-513. PMID:
16952783.
August 16, 2013 17
31. Lawson WE, Barsness G, Michaels AD, Soran O, Kennard ED, Kelsey SF, Hui JCK, for the
IEPR Investigators. Effectiveness of repeat enhanced external counterpulsation for refractory
angina in patients failing to complete an initial course of therapy. Cardiology 2006; 108:
170-175. PMID: 17085938.
32. Shah SJ, Michaels AD. Hemodynamic correlates of the third heart sound and systolic time
intervals. Congestive Heart Failure 2006; 12 (Supplement 1): 8-13. PMID: 16894268.
33. Mishell JM, Vakharia KT, Ports TA, Yeghiazarians Y, Michaels AD. Determination of
adequate coronary stent expansion using StentBoost, a novel fluoroscopic image processing
technique. Catheterization and Cardiovascular Interventions 2007; 69: 84-93. PMID:
17139686.
34. Moyers B, Shapiro M, Marcus GM, Gerber IL, McKeown B, Vessey JC, Jordan MV,
Huddleston M, Foster E, Chatterjee K, Michaels AD. Performance of
phonoelectrocardiographic left ventricular systolic time intervals and B-type natriuretic
peptide levels in the diagnosis of left ventricular dysfunction. Annals of Noninvasive
Electrocardiology 2007; 12: 89-97. PMID: 17593176.
35. Cohen J, Grossman W, Michaels AD. Portable enhanced external counterpulsation for acute
coronary syndrome and cardiogenic shock: a pilot study. Clinical Cardiology 2007; 30: 223-
228. PMID: 17492675.
36. Shapiro M, Moyers B, Marcus GM, Gerber IL, McKeown B, Vessey JC, Jordan MV,
Huddleston M, Foster E, Chatterjee K, Michaels AD. Diagnostic characteristics of
combining the phonocardiographic third heart sound with systolic time intervals for the
prediction of heart failure. Journal of Cardiac Failure 2007; 13: 18-24. PMID: 17338999.
37. Michaels AD, Viswanathan MN, Jordan MV, Chatterjee K. Computerized acoustic
cardiographic insights into the pericardial knock in constrictive pericarditis. Clinical
Cardiology 2007; 30: 450-458. PMID: 17803226.
38. Akhtar M, Ordovas K, Martin A, Higgins CB, Michaels AD. Effect of chronic sustained-
release dipyridamole on myocardial blood flow and left ventricular function in patients with
ischemic cardiomyopathy. Congestive Heart Failure 2007; 13: 130-135. PMID: 17541306.
39. Michaels AD, Bart BA, Pinto T, Lafferty J, Fung G, Kennard ED. The effects of enhanced
external counterpulsation on time-and frequency-domain measures of heart rate variability.
Journal of Electrocardiology 2007; 40: 515-521. PMID: 17532337.
40. McCullough PA, Henry TD, Kennard ED, Kelsey SF, Michaels AD, for the IEPR
Investigators. Residual high-grade angina after enhanced external counterpulsation therapy.
Cardiovascular Revascularization Medicine 2007; 8: 161-165. PMID: 17765644.
41. Tandar A, Lehman CM, Rodgers GM, Meredith KG, Muhlestein JB, Barry WH, Michaels
AD, Lee HR. Activation of anticoagulation during routine diagnostic coronary angiography.
EuroIntervention 2007; 3: 345-349.
42. Shah SJ, Marcus GM, Gerber IL, McKeown B, Vessey JC, Jordan MV, Huddleston M,
Foster E, Chatterjee K, Michaels AD. Physiology of the third heart sound: novel insights
from tissue Doppler imaging. Journal of the American Society of Echocardiography 2008;
21: 394-400. PMID: 17658724.
August 16, 2013 18
43. Loh PH, Cleland JGF, Louis AA, Kennard ED, Cook JF, Caplin JL, Barsness GW, Lawson
WE, Soran OZ, Michaels AD. Enhanced external counterpulsation in the treatment of
chronic refractory angina: a long-term follow-up outcome from the International Enhanced
External Counterpulsation Patient Registry. Clinical Cardiology 2008; 31: 159-164. PMID:
18404725.
44. Gupta S, Khan F, Shapiro M, Weeks SG, Michaels AD. The associations between tricuspid
annular plane systolic excursion (TAPSE), ventricular dyssynchrony, and ventricular
interaction in heart failure patients. European Journal of Echocardiography 2008; 9: 766-
771. PMID: 18490286.
45. Shah SJ, Nakamura K, Marcus GM, Gerber IL, McKeown BH, Jordan MV, Huddleston M,
Foster E, Michaels AD. Association of the fourth heart sound and increased left ventricular
end-diastolic stiffness. Journal of Cardiac Failure 2008; 14: 431-436. PMID: 18514937.
46. Efstratiadis S, Michaels AD. Computerized acoustic cardiographic electromechanical
activation time correlates with invasive and echocardiographic parameters of left ventricular
contractility. Journal of Cardiac Failure 2008; 14: 577-582. PMID: 18722323.
47. Weeks SG, Shapiro M, Foster E, Michaels AD. Echocardiographic predictors of change in
left ventricular diastolic pressure in heart failure patients receiving nesiritide.
Echocardiography 2008; 25: 849-855. PMID: 18986412.
48. Efstratiadis S, Kennard ED, Kelsey SF, Michaels AD, for the IEPR Investigators. Passive
tobacco exposure may impair symptomatic improvement in patients with chronic angina
undergoing enhanced external counterpulsation. BMC Cardiovascular Disorders 2008: 8: 23.
PMID: 18798998.
49. Rogers RK, Collins SP, Kontos MC, Zuber M, Arand P, Michaels AD. Diagnosis and
characterization of left ventricular hypertrophy by computerized acoustic cardiography, brain
natriuretic peptide, and echocardiography. Journal of Electrocardiology 2008; 41: 518-525.
PMID: 18804784.
50. Lee E, Michaels AD, Selvester RH, Drew BJ. Frequency of diastolic third and fourth heart
sounds with myocardial ischemia induced during percutaneous coronary intervention.
Journal of Electrocardiology 2009; 42: 39-45. PMID: 19012901.
51. Collins SP, Lindsell CJ, Kontos MC, Zuber M, Kipfer P, Attenhofer Jost C, Kosmicki D,
Michaels AD. Rapid bedside prediction of elevated filling pressure in patients with
suspected heart failure. American Journal of Emergency Medicine 2009; 27: 397-408.
PMID: 19555608.
52. Gupta S, Michaels AD. Relationship between accurate auscultation of the fourth heart sound
and level of physician experience. Clinical Cardiology 2009; 32: 69-75. PMID: 19215005.
53. Michaels AD, Tacy T, Teitel D, Shapiro M, Grossman W. Invasive left ventricular
energetics during enhanced external counterpulsation. American Journal of Therapeutics
2009; 16: 239-246. PMID: 19145208.
54. Lee E, Drew BJ, Selvester RH, Michaels AD. Sequence of electrocardiographic and acoustic
cardiographic changes and angina during coronary occlusion and reperfusion in patients
undergoing percutaneous coronary intervention. Annals of Noninvasive Electrocardiology
2009; 14: 137-146. PMID: 19419398.
August 16, 2013 19
55. Garcia JA, Agostoni P, Green NE, Maddux JT, Chen SY, Messenger JC, Casserlv IP,
Hansgen A, Wink O, Movassaghi B, Groves BM, Van den Heuvel P, Verheve S, Van
Langenhove G, Vermeersch P, Van den Branden F, Yeghiazarians Y, Michaels AD, Carroll
JD. Rotational vs. standard angiography: an image content analysis. Catheterization and
Cardiovascular Interventions 2009; 73: 753-761. PMID: 19180661.
56. Rogers RK, Stoddard GJ, Greene T, Michaels AD, Fernandez G, Freeman A, Nord J, Stehlik
J. Usefulness of adjusting for clinical covariates to improve the ability of B-type natriuretic
peptide to distinguish cardiac from noncardiac dyspnea. American Journal of Cardiology
2009; 104: 689-694. PMID: 19699346.
57. Wei Y, Xie P, Pang W, Hu D, Michaels AD, Sun Y. The relationship between the coronary
sinus and coronary artery using multislice spiral computed tomography and conventional
invasive angiography. International Journal of Cardiology 2009; 137: 276-281. PMID:
19211161.
58. Efstratiadis S, Michaels AD. Acute hemodynamic effects of intravenous nesiritide on left
ventricular diastolic function in heart failure patients. Journal of Cardiac Failure 2009; 15:
673-680. PMID: 19786256.
59. Lee E, Drew BJ, Selvester RH, Michaels AD. Diastolic heart sounds as an adjunctive
diagnostic tool with ST criteria for acute myocardial ischemia. Acute Cardiac Care 2009; 11:
229-235. PMID: 19995262.
60. Reddy BT, Patel JB, Powell DL, Michaels AD. Interatrial shunt closure devices in patients
with nickel allergy. Catheterization and Cardiovascular Interventions 2009; 74: 647-651.
PMID: 19777603.
61. Rogers RK, Stehlik J, Stoddard GJ, Greene T, Collins SP, Peacock WF, Maisel AD, Clopton
P, Michaels AD. Adjusting for clinical covariates improves the ability of BNP to distinguish
cardiac from non-cardiac dyspnea: a sub-study of HEARD-IT. European Journal of Heart
Failure 2009; 11: 1043-1049. PMID: 19812054.
62. Steenblik MH, Mineau GP, Pimentel R, Michaels AD. Population-based assessment of
familial inheritance and neurologic comorbidities among patients with an isolated atrial
septal defect. Congenital Heart Disease 2009; 4: 459-463. PMID: 19925540.
63. Michaels AD, Khan FU, Moyers B. Experienced clinicians improve detection of third and
fourth heart sounds by viewing acoustic cardiography. Clinical Cardiology 2010; 33: E36-
E42. PMID: 20127893.
64. Collins SP, Kontos MC, Michaels AD, Zuber M, Kipfer P, Attenhofer Jost CA, Roos M,
Jamshidi P, Erne P, Lindsell CJ. Utility of a bedside acoustic cardiographic model to predict
elevated left ventricular filling pressure. Emergency Medicine Journal 2010: 27: 677-682.
PMID: 20515905.
65. Smith B, Neuharth RM, Hendrix MA, McDonnall D, Michaels AD. Intravenous
electrocardiographic guidance for placement of peripherally inserted central catheters.
Journal of Electrocardiology 2010; 43: 274-278. PMID: 20206940.
66. Shah SJ, Michaels AD. Acute effects of intravenous nesiritide on cardiac contractility in
heart failure. Journal of Cardiac Failure 2010; 16: 720-727. PMID: 20797595.
August 16, 2013 20
67. Kosmicki DL, Collins SP, Kontos MC, Zuber M, Kipfer P, Attenhofer Jost C, Michaels AD.
Non-invasive prediction of left ventricular systolic dysfunction in patients with clinically
suspected heart failure using acoustic cardiography. Congestive Heart Failure 2010; 16: 249-
253. PMID: 21091608.
68. Kuppahally SS, Michaels AD, Tandar A, Gilbert EM, Litwin SE, Bader FM. Can
echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart
catheterization in end-stage heart failure patients awaiting transplantation? American Journal
of Cardiology 2010; 106: 1657-1662. PMID: 21094370.
69. Dennis A, Michaels AD, Arand P, Ventura D. Noninvasive estimation of pulmonary artery
pressure using heart sound analysis. Computers in Biology and Medicine 2010; 40: 758-764.
PMID: 20691967.
70. Gupta S, Gupta N, Arand is P, Michaels AD. Computerized acoustic cardiography correlates
with echocardiography and invasive haemodynamics after percutaneous transvenous mitral
commissurotomy. Journal of Medical Engineering & Technology 2011; 35: 59-64. PMID:
21039322.
71. Michaels AD, Mester D. Ex-vivo hemodynamic assessment of mechanical aortic valve
gradients using a high-fidelity pressure wire. Catheterization and Cardiovascular
Interventions 2011; 77: 726-732. PMID: 21061253.
72. Siddiqui IF, Michaels AD. Percutaneous patent foramen ovale closure using Helex and
Amplatzer devices without intra-procedural echocardiographic guidance. Journal of
Interventional Cardiology 2011; 24: 271-277. PMID: 21114532.
73. Karabsheh S, Michaels AD. Acoustic cardiographic indices of transmyocardial ischemia
during percutaneous coronary intervention. Acute Cardiac Care 2011; 13: 3-8. PMID:
21244232.
74. Muzzarelli S, Ordovas KG, Cannavale G, Naeger D, Michaels AD, Higgins CB. Potential of
delayed gadolinium enhancement magnetic resonance for quantification of reverse
remodeling of the peri-infarct zone in patients with ischemic cardiomyopathy treated with
chronic vasodilator therapy: initial experience. Journal of Thoracic Imaging 2012; 27: 121-
124. PMID: 21552150.
75. Senthilkumaran S, Meenakshisundaram R, Michaels AD, Thirumalaikolundusubramanian P.
Electrocardiographic changes in spontaneous pneumothorax. International Journal of
Cardiology 2011; 153: 78-80. PMID: 21911271.
76. Meenakshisundaram R, Devitdutta S, Michaels AD, Senthilkumaran S, Rajendiran C,
Thirumalaikolundusubramanian P. Significance of the intima-media thickness of carotid and
thoracic aorta in coronary artery disease in the South Indian population. Heart Views 2011;
12: 150-156. PMID: 22574240.
77. Owan TE, Roe MT, Messenger JC, Dai D, Michaels AD. Contemporary use of adjunctive
thrombectomy during primary percutaneous coronary intervention for ST-elevation
myocardial infarction in the United States. Catheterization and Cardiovascular Interventions
2012; 80: 1173-1180. PMID: 22511575.
78. Wang MX, Wu GF, Gu JL, Li L, Lu K, Yang D, Chen L, Zhang X, Luo FT, Michaels AD,
Ma H. Defective T wave combined with incomplete right bundle branch block: a new
August 16, 2013 21
electrocardiographic index for diagnosing atrial septal defect. Chinese Medical Journal
(Engl) 2012; 125: 1057-1062. PMID: 22613531.
79. Chan W, Woldeyohannes M, Colman R, Arand P, Michaels AD, Parker JD, Granton JT,
Mak S. Haemodynamic and structural correlates of the first and second heart sounds in
pulmonary arterial hypertension: an acoustic cardiography cohort study. British Medical
Journal Open 2013; 3: e002660. PMID: 23572199.
80. Loh PH, Kennard L, Michaels AD, Bourantas C, Cheillah R, Cook J, Atkin P, Cleland. The
effectiveness of enhanced external counterpulsation (EECP) in patients suffering from
chronic refractory angina previously treated with transmyocardial laser revascularization. The
International Journal of Cardiology, In Press.
Original Publications Submitted
1. Singh H, Mart CR, Michaels AD. AngioJet rheolytic thrombectomy for bioprosthetic valve
thrombosis. Journal of Interventional Cardiology.
2. Karabsheh S, Arand P, Michaels AD. Nesiritide acutely prolongs electromechanical
activation time, a non-invasive acoustic cardiographic marker of contractility. Lebanese
Medical Journal.
3. Gutpa S, Gupta N, Arand P, Michaels AD. Computerized acoustic cardiographic scoring
system for rheumatic mitral stenosis. Indian Heart Journal.
4. Masood S, Karabsheh S, Neuharth RM. Michaels AD. Non-invasive computerized acoustic
cardiographic prediction of pulmonary hypertension. Annals of Noninvasive
Electrocardiology.
II. SOCIETY CLINICAL STATEMENTS
1. Michaels AD, Spinler SA, Leeper B, Ohman EM, Alexander KP, Newby LK, Ay H, Gibler
WB, on behalf of the Acute Cardiac Care Committee of the Council on Clinical Cardiology,
Council on Quality of Care and Outcomes Research, Council on Cardiopulmonary, Critical
Care, Perioperative, and Resuscitation, Council on Cardiovascular Nursing, and Stroke
Council. Medication errors in acute cardiovascular and stroke patients: a statement from the
American Heart Association. Circulation 2010; 121: 1664-1682. PMID: 20308619.
2. Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, Jenkins JS,
Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, Zierler BK; on behalf of
the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative
and Resuscitation, Council on Peripheral Vascular Disease, and Council on Arteriosclerosis,
Thrombosis and Vascular Biology. Management of massive and submassive pulmonary
embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary
hypertension: a scientific statement from the American Heart Association. Circulation 2011;
123: 1788-1830. PMID: 21422387.
August 16, 2013 22
III. REVIEW ARTICLES
1. Michaels AD, Lederman RJ, MacGregor JS, Cheitlin MD. Cardiovascular involvement in
AIDS. Current Problems in Cardiology 1997; 22: 109-148. PMID: 9070430.
2. Michaels AD. Complex PCI: Focus on chronic total occlusions, bifurcation lesions, and left
main coronary stenoses. Applications in Imaging: Cardiac Interventions, Ocean, New Jersey:
Anderson Pub., Ltd., 1999: 43-47.
3. Michaels AD. The secondary prevention of myocardial infarction. Current Problems in
Cardiology 1999; 24: 617-680. PMID: 10526703.
4. Michaels AD, Goldschlager N. Risk stratification after acute myocardial infarction in the
reperfusion era. Progress in Cardiovascular Diseases 2000; 42: 273-309. PMID: 10661780.
5. Michaels AD, Gibson CM, Barron HV. Microvascular dysfunction in acute myocardial
infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow
phenomenon. American Journal of Cardiology 2000; 85: 50B-60B. PMID: 11076131.
6. Appleby MA, Michaels AD, Chen M, Gibson CM. Importance of the TIMI frame count:
implications for future trials. Current Controlled Trials in Cardiovascular Medicine 2000; 1:
31-34. PMID: 11714404.
7. Michaels AD, Chatterjee K. Cardiology patient pages: angioplasty versus bypass surgery for
coronary artery disease. Circulation 2002; 106: e187-190. PMID: 12460885.
8. Accad M, Michaels AD. Management after myocardial infarction. Current Treatment
Options in Cardiovascular Medicine 2002; 4: 41-54. PMID: 11792227.
9. Dauterman KW, Michaels AD, Ports TA. Is there any indication for aortic valvuloplasty in
the elderly? American Journal of Geriatric Cardiology 2003; 12: 190-196. PMID: 12732815.
10. Michaels AD, McCullough PA, Soran OZ, Lawson WE, Barsness GW, Henry TD,
Linnemeier G, Ochoa A, Kelsey SF, Kennard ED, for the IEPR Investigators. Primer:
practical approach to the selection of patients for and application of EECP. Nature Clinical
Practice Cardiovascular Medicine 2006; 3: 623-632. PMID: 17063167.
11. Chatterjee K, McGlothlin D, Michaels A. Analytic reviews: cardiogenic shock with
preserved systolic function: a reminder. Journal of Intensive Care Medicine 2008; 23: 355-
366. PMID: 18794166.
12. Rogers RK, Michaels AD. Enhanced x-ray visualization of coronary stents: clinical aspects.
Cardiology Clinics 2009; 27: 467-475. PMID: 19573718.
13. Michaels AD. PFO closure technique: one expert’s preferred method for successful closure
of patent foramen ovale. Cardiac Interventions Today, November 2009; 3: 21-23.
14. Reddy BT, Michaels AD. Acute hemodynamic effects of enhanced external
counterpulsation. Journal of Geriatric Cardiology 2010; 7: 67-73.
15. Michaels AD. Percutaneous patent foramen ovale closure without intraprocedural
echocardiography. Treatment Strategies – Interventional Cardiology 2011; 1: 90-92.
http://viewer.zmags.com/publication/05bf4a63#/05bf4a63/90.
IV. BOOKS, BOOK CHAPTERS, VIDEOS, AND COMPUTER SOFTWARE
August 16, 2013 23
1. Aanstoot HJ, Michaels A, Christgau S, Shi Y, Kim J, and Bækkeskov S. Stiff-man syndrome
and insulin-dependent diabetes mellitus: similarities and differences in autoimmune
reactions. Layzer RB, et al., Eds. Motor Unit Hyperactivity States, New York: Raven Press
Ltd., 1993: 53-67.
2. Michaels AD. Coronary artery disease. Frances C, et al., eds. Saint-Frances Guide to
Outpatient Medicine, Philadelphia: Lippincott Williams & Wilkins, 1999: 118-129.
3. Michaels AD, Ports TA. Valvuloplasty for aortic stenosis. Braunwald E, Ed. Harrison's
Online, New York: McGraw-Hill Co., 2001.
4. Michaels AD, Frances C. Saint-Frances Guide to Cardiology, Philadelphia: Lippincott
Williams & Wilkins, 2001.
5. Michaels AD. Pericardial diseases. Schmarschmidt B, Ed. PocketMedicine/Internal
Medicine, Philadelphia: PocketMedicine.com, Inc., 2001.
6. Michaels AD, Ports TA. Balloon valvuloplasty for aortic stenosis. Braunwald E, Ed.
Harrison’s Advances in Cardiology, New York: McGraw-Hill Co., 2003: 348-353.
7. Michaels AD. Acute coronary syndromes. Lead Author, Medical Knowledge Self-
Assessment Program (MKSAP) 13, Philadelphia: American College of Physicians-American
Society of Internal Medicine, 2003.
8. Michaels AD. Cardiovascular disease. Contributor, Prep for Boards, Second Edition,
Philadelphia: American College of Physicians-American Society of Internal Medicine, 2004.
9. Shah S, Cohen J, Michaels A, Foster E. Cardiovascular medicine. Le T, Baudendistel T,
Chin-Hong P, Rubinson L, Eds. First Aid for the Internal Medicine Boards. New York:
McGraw-Hill Co., 2005: 63-121.
10. Efstratiadis S, Michaels AD, Wang L, Chuan ZS, Mulungu J, Nanda N, Tuan NQ. Aortic
stenosis. Hu D, Nguyen T, Kim MH, Kwan T, Saito S, Grines C, Eds. Evidence-Based
Cardiology Practice: A 21st Century Approach. Shelton, CT: People’s Medical Publishing
House--USA, 2010: 283-302.
11. Michaels AD. Coronary heart disease. Andreoli TE, Benjamin IJ, Griggs RC, Wing EJ, Eds.
Andreoli and Carpenter’s Cecil Essentials of Medicine, Eighth Edition, Philadelphia: W.B.
Saunders, 2010.
12. Kosmicki DL, Michaels AD. Left-heart catheterization and mitral balloon valvuloplasty.
Kern MJ, Lim MJ, Goldstein JA, Eds. Hemodynamic Rounds: Interpretation of Cardiac
Pathophysiology from Pressure Waveform Analysis, Third Edition, Bangalore, India:
Macmillan Publishing Solutions, 2010.
13. Shah SK, Ivan E, Michaels AD. Cardiogenic shock in acute coronary syndromes. Chatterjee
K, Anderson M, Heistad D, Kerber RE, Eds. Cardiology: An Illustrated Textbook, New
Delhi, India, Jaypee Brothers Medical Publishers, Ltd., 2013: 949-959.
V. ABSTRACTS
1. Michaels AD, Barron HV, Maynard C, Every NR. Clinical predictors of ACE inhibitor use
after acute myocardial infarction: experience from the Second National Registry of
August 16, 2013 24
Myocardial Infarction (NRMI 2). American Heart Association Annual Scientific Sessions,
Circulation 1997; 96 (Supplement I): I-705-706.
2. Michaels AD, Barron HV, Maynard C, Every NR. Clinical predictors of ACE inhibitor use
within 24 hours of admission for acute myocardial infarction: experience from the Second
National Registry of Myocardial Infarction (NRMI 2). American Heart Association Annual
Scientific Sessions, Circulation 1998; 98 (Supplement I): I-783.
3. Michaels AD, Kennard ED, Kelsey S, Holubkov R, Spence S, Chou TM. Does optimal
diastolic augmentation predict clinical benefit from Enhanced External Counterpulsation
(EECP)?: data from the International Enhanced External Counterpulsation Patient Registry.
European Society of Cardiology Annual Scientific Meeting, European Heart Journal 2000;
21 (Abstract Supplement): 173.
4. Michaels AD, Ports TA. Use of a percutaneous arterial suture device (Perclose) in patients
undergoing percutaneous balloon aortic valvuloplasty. Transcatheter Cardiovascular
Therapeutics 12th Annual Symposium, American Journal of Cardiology 2000; 86
(Supplement 8A): 55i. Presenter.
5. Michaels AD, Dauterman K, Malik F, Ports TA, Gibson CM, Shunk K, Chou TM.
Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of
saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention of
no reflow (VAPOR) trial. American College of Cardiology Annual Scientific Sessions,
Journal of the American College of Cardiology 2001; 37 (Supplement A): 24A. Presenter.
6. Gibson CM, Luu LL, Kermgard SR, Hynes CA, Otten MH, Lim JS, Appleby M, Michaels
A, Marble SJ, Murphy SA, Barron HV. Validation of myocardial perfusion grades using
digital subtraction angiography (DSA). American College of Cardiology Annual Scientific
Sessions, Journal of the American College of Cardiology 2001; 37 (Supplement A): 333A.
7. Appleby MA, Otten MH, Gibson CM, Michaels AD. Intracoronary verapamil prior to
intervention in vein grafts improves flow and myocardial perfusion. British Cardiac Society
Annual Conference, Heart 2001; 85 (Supplement I): P26.
8. Michaels AD, Kelsey S, Holubkov R, Kennard ED. Efficacy of enhanced external
counterpulsation (EECP) for patients who are not candidates for coronary revascularization:
immediate and one-year clinical outcomes from the International EECP Patient Registry.
Transcatheter Cardiovascular Therapeutics 13th Annual Symposium, American Journal of
Cardiology 2001; 88 (Supplement 5A): 103G-104G. Presenter.
9. Soran O, Michaels AD, Kennard ED, Kelsey S, Holubkov R, Feldman AM. Is diastolic
augmentation an important predictor of treatment completion for patients with left ventricular
dysfunction undergoing enhanced external counterpulsation for angina? 5th
Annual Heart
Failure Society Association Annual Scientific Meeting, Journal of Cardiac Failure 2001; 7:
99.
10. Soran O, Michaels AD, Kennard ED, Kelsey S, Feldman AM. The incidence of repeat
enhanced external counterpulsation in patients with refractory angina who are not candidates
for invasive revascularization: results from the International EECP Patient Registry. Society
for Cardiac Angiography & Intervention, Catheterization and Cardiovascular Interventions
2002; 56: 136. Presenter.
August 16, 2013 25
11. Michaels AD, Klein A, Lakshmi MV, Chatterjee K. Effects of intravenous nesiritide on
coronary vasomotor regulation and myocardial oxygen consumption. 6th
Annual Heart
Failure Society Association Annual Scientific Meeting, Journal of Cardiac Failure 2002; 8
(Supplement 4): S17. Presenter.
12. Michaels AD, Klein A, Lakshmi MV, Chatterjee K. Effects of intravenous nesiritide on
coronary vasomotor regulation and myocardial oxygen consumption. Transcatheter
Cardiovascular Therapeutics 14th Annual Symposium, American Journal of Cardiology
2002; 90 (Supplement 6A): 160H. Presenter.
13. Michaels AD, Ports TA, Grossman W. Intracoronary hemodynamics during enhanced
external counterpulsation (EECP). American Heart Association, Western States Affiliate
2002 Young Investigators Forum, San Diego State University, September 13, 2002.
Presenter.
14. Michaels AD, Grossman W. Intracoronary hemodynamics during enhanced external
counterpulsation (EECP). 2nd
Place Clinical Research Junior Faculty Award, 8th
Annual
AstraZeneca Cardiovascular Young Investigators’ Forum, October 13, 2002. Presenter.
15. Michaels AD, Ports TA, Grossman W. Intracoronary hemodynamics during enhanced
external counterpulsation. 3rd
Annual Clinical Research Symposium, UCSF Clinical
Research Program, October 25, 2002. Presenter.
16. Michaels AD, Accad M, Madden J, Dauterman K, Ports TA, Grossman W. Augmentation of
intracoronary pressure and left ventricular systolic unloading during enhanced external
counterpulsation. American Heart Association’s Scientific Sessions, Samuel A. Levine
Young Clinical Investigator Award Finalist, Circulation 2002; 106 (Supplement II): II-319-
II-320. Presenter.
17. Michaels AD, Linnemeier G, Soran O, Kennard ED. Two-year outcomes after enhanced
external counterpulsation: data from the International EECP Patient Registry. American
College of Cardiology Annual Scientific Sessions, Journal of the American College of
Cardiology 2003; 41 (Supplement A): 379A. Presenter.
18. Michaels AD, Klein A, Chatterjee K. Effects of intravenous nesiritide on coronary
vasomotor regulation and myocardial oxygen extraction. American College of Cardiology
Annual Scientific Sessions, Journal of the American College of Cardiology 2003; 41
(Supplement A): 205A. Presenter.
19. Marcus G, Michaels AD, DeMarco T, Chatterjee K. Can the presence of an S3 predict
elevated B-type natriuretic peptide levels? American College of Cardiology Annual
Scientific Sessions, Journal of the American College of Cardiology 2003; 41 (Supplement
A): 143A.
20. Michaels AD, Kelsey S, Soran O, Kennard ED. Geographic variation in secondary
prevention pharmacologic therapy in patients with chronic angina undergoing treatment with
enhanced external counterpulsation. 5th
International Congress on Coronary Artery Disease:
From Prevention to Intervention, Journal of Coronary Artery Disease 2003; 5: 191.
21. Kane JP, Aouizerat BE, Luke MM, Shiffman D, Iakoubova O, Liu D, Rowland CM,
Catanese JJ, Leong DU, Lau KF, Louie JZ, Tong CH, McAllister LB, Dabby L, Ports TA,
Michaels AD, Zellner C, Pullinger CR, Malloy MJ, Devlin JJ. Novel genetic markers for
August 16, 2013 26
structural coronary artery disease, myocardial infarction, and familial combined
hyperlipidemia: candidate and genomic scans of functional SNPs. Proceedings of the
International Arteriosclerosis Society, Kyoto, Japan, 2003.
22. Michaels AD, Chatterjee K, Madden J, DeMarco T. Hemodynamic effects of intravenous
nesiritide in patients with pulmonary hypertension. American College of Cardiology Annual
Scientific Sessions, Journal of the American College of Cardiology 2004; 43 (Supplement
A): 192A.
23. Michaels AD, Kelsey S, Soran O, Kennard ED. Marked underutilization and geographic
variation in secondary prevention pharmacologic therapy in patients with chronic angina
undergoing treatment with enhanced external counterpulsation. American College of
Cardiology Annual Scientific Sessions, Journal of the American College of Cardiology 2004;
43 (Supplement A): 407A. Presenter.
24. Michaels AD, Raisinghani A, Soran O, de Lame P-A, Lemaire ML, Kligfield P, Watson DD,
Beller G. The effects of enhanced external counterpulsation on myocardial perfusion in
patients with stable angina: a single-blind multicenter pilot study. American College of
Cardiology Annual Scientific Sessions, Journal of the American College of Cardiology 2004;
43 (Supplement A): 308A.
25. McKeown B, Gerber I, Michaels AD, Chatterjee K, Foster E. Levosimendan improves left
ventricular systolic function and mechanical efficiency while reducing end-systolic
meridional wall stress. 8th
Annual Heart Failure Society Association Annual Scientific
Meeting, Journal of Cardiac Failure 2004; 10 (Supplement 4): S30.
26. Michaels AD, Vakharia KT, Kostal M, Jordan MV, Chatterjee K. Effects of levosimendan
on coronary vasomotor regulation and myocardial oxygen extraction. 8th
Annual Heart
Failure Society Association Annual Scientific Meeting, Journal of Cardiac Failure 2004; 10
(Supplement 4): S91.
27. Michaels AD, Harmon CT, Johengen M, Fineman J, Chatterjee K, De Marco T. Effects of
nesiritide on trans-pulmonary blood levels of nitric oxide and cyclic GMP in patients with
pulmonary hypertension. 8th
Annual Heart Failure Society Association Annual Scientific
Meeting, Journal of Cardiac Failure 2004; 10 (Supplement 4): S31.
28. Gerber IL, McKeown BH, Marcus G, Vessey J, Jordan MV, Huddleston M, Foster E,
Chatterjee K, Michaels AD. Third and fourth heart sounds are highly specific markers for
elevated left ventricular filling pressure and reduced ejection fraction. 8th
Annual Heart
Failure Society Association Annual Scientific Meeting, Journal of Cardiac Failure 2004; 10
(Supplement 4): S36.
29. Gerber IL, McKeown BH, Huddleston M, Jordan MV, Chatterjee K, Foster E, Michaels AD.
Echocardiographic, neurohormonal and invasively measured correlates of third and fourth
heart sounds determined by audioelectric cardiography. Journal of the American Society of
Echocardiography 2004; 17: 523.
30. Jordan MV, Marcus G, Vessey J, Gerber IL, McKeown BH, Huddleston M, Foster E,
Chatterjee K, Michaels AD. Third and fourth heart sounds detected by correlated
audioelectric cardiography are highly specific markers for elevated left ventricular filling
pressure and reduced ejection fraction. American College of Emergency Physicians
Scientific Assembly, Annals of Emergency Medicine 2004; 44: S73.
August 16, 2013 27
31. Michaels AD, Harmon CT, Johengen M, Fineman J, Chatterjee K, De Marco T. Nesiritide
acutely increases pulmonary and systemic levels of nitric oxide and cGMP in pulmonary
hypertension patients. American Heart Association’s Annual Scientific Sessions, Circulation
2004; 110 (Supplement III): III-555-556.
32. Lee E, Michaels AD, Schindler D, Drew B. Superiority of P-wave amplitude over P-wave
duration to predict left ventricular end diastolic pressure. International Society for
Computerized Electrocardiography Scientific Sessions, Journal of Electrocardiology 2005;
38 (Supplement 4).
33. Warner RA, Lee E, Arand P, Michaels AD, Drew BJ. Using simultaneous ECG and
acoustical data to evaluate and monitor patients with cardiac disease. International Society
for Computerized Electrocardiography Scientific Sessions, Journal of Electrocardiology
2005; 38 (Supplement 4): 144.
34. Akhtar M, Vakharia KT, Mishell JM, Gera A, Ports TA, Yeghiazarians Y, Michaels AD.
Randomized study of the safety and clinical utility of rotational versus standard coronary
angiography using a flat-panel detector. Catheterization and Cardiovascular Interventions
2005; 65: 129.
35. Vakharia KT, Mishell JM, Yeghiazarians Y, Ports TA, Michaels AD. Determination of
adequate stent expansion: a comparison of stent boost x-ray imaging versus intravascular
ultrasound. Catheterization and Cardiovascular Interventions 2005; 65: 140.
36. Vakharia KT, Mishell JM, Yeghiazarians Y, Ports TA, Michaels AD. Determination of
adequate stent expansion: a comparison of quantitative coronary angiography, intravascular
ultrasound, and novel stent boost x-ray imaging. Transcatheter Cardiovascular Therapeutics
17th Annual Symposium, American Journal of Cardiology 2005; 96 (Supplement): 195H.
37. Shah SJ, Marcus GM, MD, Gerber IL, McKeown BH, Vessey JC, Jordan MV, Huddleston
M, Foster E, Chatterjee K, Michaels AD. High-sensitivity C-reactive protein and parameters
of left ventricular dysfunction. American Heart Association’s Annual Scientific Sessions,
Circulation 2005; 112 (Supplement II): II-724.
38. Shah SJ, Zaroff JG, Michaels AD, Crawford MH. Laennec Young Clinician Award. Haunted
by her past: a 56-year-old woman with brain abscess and multiple dysmorphic features.
American Heart Association’s Annual Scientific Sessions, Circulation 2005; 112
(Supplement II): II-628.
39. Loh PH, Windram J, Kennard ED, Louis AA, Cook J, Rigby AS, Michaels AD, Cleland
JGF. Enhanced external counterpulsation (EECP) in the treatment of chronic stable refractory
angina: a multicentre prospective long-term follow-up outcome. European Heart Journal
2005; 26 (Supplement): 71.
40. Michaels AD, Marcus GM, Jordan MV, Gerber IL, McKeown BH, Huddleston M, Foster E,
Chatterjee K. Audioelectric parameters are superior to BNP for detecting hemodynamic
evidence of heart failure. American College of Cardiology Annual Scientific Sessions,
Journal of the American College of Cardiology 2006; 47 (Supplement A): 67A. Presenter.
41. Lee E, Drew BJ, Selvester SH, Schindler DM, Michaels AD. Novel computer assisted
measurement of electrocardiographic P terminal force to predict elevated left ventricular end
August 16, 2013 28
diastolic pressure. American College of Cardiology Annual Scientific Sessions, Journal of
the American College of Cardiology 2006; 47 (Supplement A): 13A.
42. Shah SJ, Marcus GM, Gerber IL, McKeown B, Chatterjee K, Foster E, Michaels AD.
Physiology of the third heart sound: novel insights from tissue Doppler imaging and invasive
left ventricular hemodynamics. Journal of the American Society of Echocardiography 2006;
19: 582.
43. Shah SJ, Marcus GM, Gerber IL, McKeown B, Jessey J, Jordan MV, Huddleston M, Foster
E, Chatterjee K, Michaels AD. The fourth heart sound is associated with increased left
ventricular end-diastolic elastance. American Heart Association’s Annual Scientific Sessions,
Circulation 2006; 114 (Supplement II): II-803.
44. Moyers B, Michaels AD. Experienced clinicians improve auscultatory detection of third and
fourth heart sounds by adding phonocardiography. International Society for Computerized
Electrocardiography Scientific Sessions, J Electrocardiol 2007; 40 (Supplement 1): S84.
Presenter.
45. Efstratiadis S, Palfreyman E, Shapiro M, Weeks SG, Foster E, Michaels AD. Computerized
acoustic cardiographic electromechanical activation time correlates with invasive and
echocardiographic parameters of left ventricular contractility. International Society for
Computerized Electrocardiography Scientific Sessions, J Electrocardiol 2007; 40
(Supplement 1): S31.
46. Warner RA, Arand PA, Michaels AD. QRS-T angle for detecting left ventricular systolic
dysfunction. International Society for Computerized Electrocardiography Scientific Sessions,
J Electrocardiol 2007; 40 (Supplement 1): S86.
47. Collins SP, Lindsell CJ, Zuber M, Kontos MC, Attenhofer Jost CH, Kipfer P, Kosmicki D,
Michaels AD. Bedside prediction of elevated filling pressures in heart failure patients.
American College of Cardiology Annual Scientific Sessions, Journal of the American
College of Cardiology 2007; 49 (Supplement A): 80A.
48. Shah SJ, Weeks SG, Shapiro M, Foster E, Michaels AD. Intravenous nesiritide decreases
contractility in humans: observations from pressure-volume analysis. American College of
Cardiology Annual Scientific Sessions, Journal of the American College of Cardiology 2007;
49 (Supplement A): 75A.
49. Efstratiadis S, Shapiro M, Weeks SG, Foster E, Michaels AD. Acoustic cardiography
correlates with invasive and echocardiographic systolic and diastolic hemodynamic
parameters. American College of Cardiology Annual Scientific Sessions, Journal of the
American College of Cardiology 2007; 49 (Supplement A): 68A.
50. Meredith KG, Tandar A, Lappé DL, May HT, Michaels AD, Anderson JL, Muhlestein JB.
Effects of drug-eluting stents on hospital readmission rates and long-term repeat
revascularization: outcomes from a large clinical registry. American College of Cardiology
Annual Scientific Sessions, Journal of the American College of Cardiology 2007; 49
(Supplement A): 287A.
51. Meredith KG, Badger RS, Tandar A, May HT, Bair TL, Kosmicki DL, Michaels AD,
Anderson JL, Horne BD, Muhlestein JB. Stent thrombosis in the modern drug-eluting stent
era compared to the bare-metal stent era: a comparison from a large clinical registry.
August 16, 2013 29
American College of Cardiology Interventional Annual Scientific Sessions, Journal of the
American College of Cardiology 2007; 49 (Supplement B): 24B.
52. Kosmicki DL, Shapiro M, Weeks SG, Foster E, Michaels AD. The effect of nesiritide on left
ventricular diastolic function. American College of Cardiology Annual Scientific Sessions,
Journal of the American College of Cardiology 2007; 49 (Supplement A): 55A.
53. Abedin M, Pai RK, Tandar A, Patel JB, Daccarett M, Segerson NM, Michaels AD, Klein
RC. Acute inferior ST segment elevation myocardial infarction complicating radiofrequency
ablation of a slow pathway for the treatment of atrioventricular nodal reentrant tachycardia.
Heart Rhythm Scientific Sessions Heart Rhythm 2007; 4: S270.
54. Arand P, Michaels AD, Kontos MC, Warner R, Gasperina MD, Hesler S. Combined ECG
and heart sounds parameters identify patients with systolic dysfunction with or without
elevated pressure. 11th
Annual Heart Failure Society Association Annual Scientific Meeting,
Journal of Cardiac Failure 2007; 13: S184.
55. Kosmicki DL, Collins SP, Lindsell CJ, Zuber M, Kontos MC, Kipfer P, Jost CA, Michaels
AD. Non-invasive computerized acoustic cardiographic prediction of left ventricular systolic
dysfunction. American College of Cardiology Annual Scientific Sessions, Journal of the
American College of Cardiology 2008; 51 (Supplement A): A268.
56. Lawson WE, Hui JCK, Kennard ED, Silver MA, Soran O, Kelsey SF, Barsness G, Michaels
AD. Enhanced external counterpulsation improves one year mortality in angina patients with
end stage coronary disease. American College of Cardiology Annual Scientific Sessions,
Journal of the American College of Cardiology 2008; 51 (Supplement A): A231.
57. Efstratiadis S, Warner RA, Kontos MC, Zuber M, Arand P, Michaels AD. Acoustic
cardiographic electromechanical activation time correlates with echocardiographic
parameters of left ventricular contractility in patients with myocardial ischemia. International
Society for Computerized Electrocardiography Scientific Sessions, Journal of
Electrocardiology 2008; 41: 638.
58. Efstratiadis S, Warner RA, Kontos MC, Zuber M, Arand P, Michaels AD. Acoustic
cardiographic and echocardiographic evidence of hemodynamic abnormalities associated
with prior myocardial infarction. International Society for Computerized Electrocardiography
Scientific Sessions, Journal of Electrocardiology 2008; 41: 643.
59. Lee E, Michaels AD, Selvester R, Drew B. Diastolic heart sounds as a predictor of acute
myocardial ischemia. International Society for Computerized Electrocardiography Scientific
Sessions, Journal of Electrocardiology 2008; 41: 645.
60. Karabsheh S, Arand P, Michaels AD. Acoustic electrocardiographic indices of
transmyocardial ischemia. International Society for Computerized Electrocardiography
Scientific Sessions, Journal of Electrocardiology 2008; 41: 639.
61. Collins SP, Kontos MC, Zuber, M, Kosmicki D, Michaels AD, Jost CA, Kipfer P, Roos M,
Jamshidi P, Erne P, Lindsell CJ. Validation of a noninvasive bedside model to predict
elevated filling pressures. 12th
Annual Heart Failure Society Association Annual Scientific
Meeting, Journal of Cardiac Failure 2008; 14: S54.
62. Karabsheh SM, Michaels AD. Nesiritide acutely prolongs electromechanical activation time,
a non-invasive acoustic cardiographic marker of contractility, in heart failure patients. 12th
August 16, 2013 30
Annual Heart Failure Society Association Annual Scientific Meeting, Journal of Cardiac
Failure 2008; 14: S11.
63. Karabsheh SM, Michaels AD. The fourth heart sound is associated with increased left
ventricular stiffness assessed by invasive and echocardiographic methods. 12th
Annual Heart
Failure Society Association Annual Scientific Meeting, Journal of Cardiac Failure 2008; 14:
S28.
64. Parker JD, Michaels AD, Kass DA, Wolff AA, Felker GM, Malik FI. Rationale and design
for a phase II study evaluating the effect of the cardiac myosin activator, CK-1827452, on
cardiac function, hemodynamics, and myocardial oxygen consumption in patients with heart
failure. 12th
Annual Heart Failure Society Association Annual Scientific Meeting, Journal of
Cardiac Failure 2008; 14: S79.
65. Lee E, Michaels AD, Selvester RH, Drew BJ. Ischemic cascade: sequence of ECG, acoustic
cardiographic changes, and angina during coronary occlusion. American Heart Association’s
Annual Scientific Sessions, Circulation 2008; 118 (Supplement 2): S760.
66. Lee E, Michaels AD, Selvester RH, Drew BJ. Frequency of diastolic third and fourth heart
sounds with myocardial ischemia during percutaneous coronary intervention. American
Heart Association’s Annual Scientific Sessions, Circulation 2008; 118 (Supplement 2):
S639.
67. Michaels AD, Neuharth RM, Hendrix MA, McDonnall D, Hiatt S. Intravenous
electrocardiographic guidance for placement of peripherally inserted central catheters.
International Society for Computerized Electrocardiography Scientific Sessions, Journal of
Electrocardiology, 2009; 42: 617. Presenter.
68. Michaels AD, Karabsheh S, Neuharth RM, Masood S, Arand P. Non-invasive computerized
acoustic cardiographic prediction of pulmonary hypertension. International Society for
Computerized Electrocardiography Scientific Sessions, Journal of Electrocardiology, 2009;
42: 617. Presenter.
69. Lee E, Michaels AD, Selvester RH, Drew BJ. P-terminal force changes with ischemia
induced by percutaneous coronary intervention. International Society for Computerized
Electrocardiography Scientific Sessions, Journal of Electrocardiology, 2009; 42: 616.
70. Michaels AD, Steenblik MH, Pimentel R, Mineau GP. Familial kinship analysis of the Utah
population database demonstrates a strong familial risk for patients with atrial shunt.
European Society of Cardiology Scientific Sessions, European Heart Journal 2009; 30
(Abstract Supplement): 993, Presenter.
71. Michaels AD, Rogers RK, Stoddard G, Greene T, Collins SP, Peacock WF, Clopton P,
Maisel AD, Nowak R, Stehlik J. Adjusting for clinical covariates improves the ability of
BNP to distinguish cardiac from non-cardiac dyspnea. European Society of Cardiology
Scientific Sessions, European Heart Journal 2009; 30 (Abstract Supplement): 131,
Presenter.
72. Kuppahally SS, Gilbert EM, Litwin SE, Ishihara S, Neuharth R, Michaels AD, Tandar A,
Bader F. Can echocardiographic evaluation of cardiopulmonary hemodynamics replace right
heart catheterization in end-stage heart failure patients awaiting transplantation? American
August 16, 2013 31
College of Cardiology Annual Scientific Sessions, Journal of the American College of
Cardiology 2010; 55 (Supplement A): A26.
72. Michaels AD, Owan TE, Dai D, Messenger JC, Roe MT. Temporal trends in the use of
thrombectomy during primary percutaneous coronary intervention for ST elevation
myocardial infarction in the United States. Transcatheter Cardiovascular Therapeutics 21st
Annual Symposium, Journal of the American College of Cardiology 2010; 56 (Supplement
B): B103.
73. Chan W, Woldeyohannes M, Colman R, Arand P, Michaels AD, Granton JT, Mak S.
Detection of pulmonary arterial hypertension and ventricular interaction by digital acoustic
phonocardiography. American College of Cardiology Annual Scientific Sessions, Journal of
the American College of Cardiology 2012, In Press.
VI. OTHER (Letters/Editorials/Case Reports/Video/Film)
Case Series/Case Reports:
1. Michaels AD, Goldschlager N. Diminutive Russian prosthetic heart valve as an iatrogenic
cause of mitral stenosis. Western Journal of Medicine 1997; 166: 347-350. PMID: 9217444.
2. Michaels AD, Whisenant B, MacGregor JS. Multivessel coronary thrombosis treated with
abciximab (ReoPro) in a patient with essential thrombocythemia. Clinical Cardiology 1998;
21: 134-138. PMID: 9491958.
3. Michaels AD, Frances CD. Images in cardiovascular medicine: tremor on the
electrocardiogram. Circulation 1998; 98: 184-185. PMID: 9679726.
4. Michaels AD, Chou TM. Images in cardiology: the Vineberg procedure. Heart 1999; 82:
569. PMID: 10525510.
5. Tandar A, Whisenant BK, Michaels AD. Stent fracture following stenting of a myocardial
bridge: report of 2 cases. Catheterization and Cardiovascular Interventions 2008; 71: 191-
196. PMID: 18327836.
6. Kosmicki D, Michaels AD. Hemodynamic rounds series: left heart catheterization and mitral
balloon valvuloplasty in a patient with a mechanical aortic valve. Catheterization and
Cardiovascular Interventions 2008; 71: 429-433. PMID: 18288758.
7. Karabsheh S, Neuharth RM, Hamdan MH, Michaels AD. Acoustic cardiography recording
during ventricular fibrillation. Resuscitation 2008; 78: 374-377. PMID: 18562076.
8. Jiji RS, Michaels AD. Heparin-induced thrombocytopenia (HIT) causing pulmonary emboli
during coronary intervention. Catheterization and Cardiovascular Interventions 2008; 72:
819-822. PMID: 18798244.
9. Rabkin DG, Whitehead KJ, Michaels AD, Powell DL, Karwande SV. Unusual presentation
of nickel allergy requiring explantation of Amplatzer atrial septal occluder device. Clinical
Cardiology 2009; 32: E55-E57. PMID: 19455702.
August 16, 2013 32
10. Michaels AD, Burlew BS. Pacemaker lead thrombus causing cryptogenic stroke in a patient
referred for percutaneous patent foramen ovale closure. Journal of Invasive Cardiology 2009;
21: E224-E225. PMID: 19901425.
11. Kuppahally SS, Green LS, Michaels AD, Ishihara SM, Freedman RA, Litwin SE.
Inadvertent placement of pacemaker lead into the systemic ventricle in repaired D-
transposition of the great arteries. Circulation 2010; 121: e32. PMID: 20159837.
12. Kuppahally SS, Litwin SE, Green LS, Ishihara SM, Freedman RA, Michaels AD. Utility of
intracardiac echocardiography for atrial baffle leak closure in repaired transposition of the
great arteries. Echocardiography 2010; 27: E90-E93. PMID: 20849476.
13. Kuppahally SS, Litwin SE, Michaels AD. Endomyocardial biopsy of right atrial
angiosarcoma guided by intracardiac echocardiography. Cardiology Research and Practice
2010; 2010: 681726. PMID: 20585357.
14. Owan TE, Reddy BT, Michaels AD. Retrograde left ventricular hemodynamic assessment of
mechanical aortic and mitral valve gradients using a high-fidelity pressure wire: a case series.
Catheterization and Cardiovascular Interventions 2010; 76; 621-625. PMID: 20882666.
15. Senthilkumaran S, Meenakshisundaram R, Michaels AD, Thirumalaikolundusubramanian P.
Electrocardiographic changes during inhalational oleander toxicity. Journal of
Electrocardiology 2011; 44: 470-472. PMID: 21397908.
16. Senthilkumaran S, Meenakshisundaram R, Michaels AD, Suresh P,
Thirumalaikolundusubramanian P. Cardiovascular complications in ciguatera fish poisoning:
a wake-up call. Heart Views 2011; 12: 166-168. PMID: 22574244 .
17. Senthilkumaran S, Meenakshisundaram R, Michaels AD, Suresh P,
Thirumalaikolundusubramanian P. Acute ST-segment elevation myocardial infarction from a
centipede bite. Journal of Cardiovascular Disease Research 2011; 2: 244-246. PMID:
22135485.
18. Senthilkumaran S, Meenakshisundaram R, Michaels AD, Balamurgan N,
Thirumalaikolundusubramanian P. Ventricular fibrillation after exposure to air freshner –
death just a breath away. Journal of Electrocardiology 2012; 45: 164-166. PMID: 21696756.
19. Senthilkumaran S, Meenakshisundaram R, Michaels AD, Thirumalaikolundusubramanian P.
Isolated thigh pain in myocardial infarction. Americal Journal of Emergency Medicine 2013;
31: 998e1-2. PMID: 23481159.
20. Wasik K, Michaels AD. Acute delirium induced by carvedilol: a case report. Journal of
Medical Cases 2013; 4: 732-733.
Editorials/Letters:
1. Montauk L, Michaels AD, Barsotti M. False-positive end-tidal CO2 [Letter]. Annals of
Emergency Medicine 1996; 28: 458-459. PMID: 8839539.
2. Michaels AD. Risk of stroke after myocardial infarction [Letter]. New England Journal of
Medicine 1997; 336: 1916. PMID: 9198759.
August 16, 2013 33
3. Michaels AD. Noninvasive detection of coronary artery disease [Letter]. New England
Journal of Medicine 1999; 340: 1595. PMID: 10336364.
4. Michaels AD. Many high-risk patients do not receive lipid lowering drugs when discharged
after acute myocardial infarction [Commentary]. Evidence-Based Healthcare 2001; 5: 89-90.
5. Michaels AD, Kohn MA. Likelihood ratio reporting [Letter]. Mayo Clinic Proceedings
2005; 80: 563. PMID: 15819297.
6. Mishell J, Michaels AD. Effects of enhanced external counterpulsation on hemodynamics
and its mechanism: relation to neurohumoral factors [Letter]. Circulation Journal 2005; 69:
257. PMID: 15700384.
7. Michaels AD, Soran O. Graduated pressure regimen for external counterpulsation (ECP) for
patients with heart failure [Letter]. Congestive Heart Failure 2005; 11: 278. PMID:
16312057.
8. Cohen J, Michaels AD. Is it time for elective left main percutaneous coronary intervention to
become 'main stream'? [Editorial]. Journal of Geriatric Cardiology 2006; 3: 57-58.
9. Gupta S, Michaels AD. Bare metal stent restenosis: the outcome classification used by Chen
et al is troublesome [Letter]. American Heart Journal 2007; 153: e5. PMID: 17307407.
10. Michaels AD, Powell DL, Whitehead KJ. Reply to a letter to editor “nickel allergy,
Amplatzer atrial septal occluder device, and the risk of Kounis syndrome. Clinical
Cardiology 2010; 33: E61. PMID: 20394036.
11. Michaels AD. Medical societies target overused cardiac stress tests. North Coast Physician
June 2012: 7.
VII. ORAL PRESENTATIONS
Meeting Presentations
International Invited Presentations
1. ENTIRE TIMI 23 Investigators’ Meeting, Paris, France, January 15, 2000: “General
Guidelines for Performing Coronary Angiography for the ENTIRE TIMI 23 Investigators’
Meeting.”
2. Pre-Congress Symposium on Stem Cell Therapy for Heart Disease, Hanoi, Vietnam, April
25, 2004: “Current Status of Stem Cell Transplantation.”
3. 1st National Conference on Interventional Cardiology, Hanoi, Vietnam, April 26, 2004:
“Drug-Eluting Stents.”
4. 10th
Vietnam National Congress of Cardiology, Hanoi, Vietnam, April 27, 2004: “Novel
Options for Refractory Angina.”
5. Shanghai Railway Central Hospital Cardiology Meeting, Shanghai, China, April 29-30,
2004: “Guiding Catheters for Coronary Intervention,” “Guidewires for Coronary
Intervention,” and “Complex Percutaneous Coronary Intervention.”
August 16, 2013 34
6. International Symposium on Acute Coronary Syndrome Evaluation & Strategy (ACSES)
with Live Demonstration, Beijing, China, July 31, 2004: “Drug-Eluting Stents for Primary
PCI in ST-Elevation Myocardial Infarction” and “Stem Cell Therapy in Acute Myocardial
Infarction.”
7. 53rd
Annual Scientific Session of the Japanese College of Cardiology, Osaka, Japan,
September 21, 2005: “New Insights in Detecting Hemodynamic Abnormalities in Patients
with Heart Failure.”
8. 1st International External Counterpulsation (ECP) Symposium, Guangzhou, China, May
13-14, 2006: “Acute Coronary and Myocardial Hemodynamic Effects of EECP” and
“PEECH Study Review: EECP in Heart Failure.”
9. Beijing Military General Hospital, Interventional Cardiology Grand Rounds, Beijing,
China, August 1, 2005: “Complex Percutaneous Coronary Interventions.”
10. Tongji University Hospital, Medicine Grand Rounds, Shanghai, China, August 2, 2005:
“Immediate Reperfusion Therapy for Acute Myocardial Infarction.”
11. 1st Hospital of Sun Yat-sen University, Key Laboratory on Assisted Circulation Grand
Rounds, August 5, 2005: “EECP for Refractory Angina and Heart Failure.”
12. Sun Yat-sen Medical Forum: Endovascular Intervention, Guangzhou, China, September 15,
2007: “New Era of Stenting for Coronary Artery Disease: Current Controversies and
Future Opportunities.”
13. 8th
National Cardiology Congress of Integration of Traditional and Western Medicine,
Guangzhou, China, September 15, 2007: “Drug-Eluting Stenting for Coronary Artery
Disease.”
14. Jiangsu Province Hospital, Cardiology Grand Rounds, Nanjing, China, November 30,
2007: “Drug-Eluting Stents.”
15. International Symposium on the Advancement of Acute Coronary Syndrome Evaluation
and Strategy (ACSES) with Live Demonstration and Fellow Courses, Beijing, China,
December 1, 2007: “Drug-Eluting Stenting for Acute Coronary Syndromes: Current
Controversies and Future Opportunities.” December 2, 2007: “Cardiogenic Shock in the
Reperfusion Era.”
16. 17th
ASEAN Congress of Cardiology, Hanoi, Vietnam, October 19, 2008: “Live PCI Case
Demonstration,” and “Acoustic Cardiography During Percutaneous Coronary
Intervention;” October 20, 2008, Chairperson “Symposium of Stroke and PAD,” Lecturer
“Update on PFO Closure for Migraine Headache.”
17. International ACC Delegation, Fudan University, Shanghai, China, October 21, 2008:
“Advances in Management of Cardiogenic Shock.”
18. Endovascology 2008, Changhai Teaching Hospital and the Second Military Medical
University, Shanghai, China, October 23, 2008: “PFO Closure for Migraine Headache.”
19. Great Wall International Congress of Cardiology, Beijing, China, October 25, 2008:
“Enhanced External Counterpulsation for End-Stage Coronary Artery Disease.”
August 16, 2013 35
20. Sun Yat-sen Medical Forum and the 3rd
Southern Endovascular Congress, Guangzhou,
China, May 8-9, 2009: “Percutaneous Patent Foramen Ovale Closure: Controversies and
Accomplishments,” and “Fluoroscopic-Only Guidance for PFO Closure.”
21. International Forum of Cardiovascular Rehabilitation and the Second International EECP
Symposium, at the Great Wall International Congress of Cardiology, Beijing, China,
October 9, 2009: “Acute Hemodynamic Effects of EECP.”
22. Great Wall International Congress of Cardiology, Beijing, China, October 11, 2009:
“Nickel Allergy to Intracardiac Shunt Closure Devices.”
23. Great Wall International Congress of Cardiology, Beijing, China, October 12, 2013: “Acute
Hemodynamic Effects of EECP.”
National Invited Presentations
1. American Heart Association 70th Scientific Sessions, Orlando, FL, November 12, 1997:
“Clinical Predictors of ACE Inhibitor Use After Acute Myocardial Infarction: Experience
from the Second National Registry of Myocardial Infarction (NRMI 2) [abstract oral
presentation].”
2. American Heart Association 71st Scientific Sessions, New Orleans, LA, November 11,
1998: “Clinical Predictors of ACE Inhibitor Use Within 24 Hours of Admission for Acute
Myocardial Infarction: Experience from the Second National Registry of Myocardial
Infarction (NRMI 2) [abstract oral presentation].”
3. International Enhanced External Counterpulsation Patient Registry Scientific Meeting,
Anaheim, CA, March 13, 2000: “Does Optimal Diastolic Augmentation Predict Clinical
Benefit from Enhanced External Counterpulsation (EECP)?”
4. American College of Cardiology 50th Annual Scientific Session, Orlando, FL, March 19,
2001: “European Society of Cardiology/American College of Cardiology Joint
Symposium-- Management of Acute Myocardial Infarction: Risk Stratification: When and
How?”
5. The PolyClinic, Seattle, WA, January 8, 2002: “Enhanced External Counterpulsation.”
6. Apex Cardiology Symposium, Carlsbad, CA, October 6, 2002: “Enhanced External
Counterpulsation.”
7. 26th
Annual Cardiology Update, Carmel, CA, October 10, 2002: “Newer Techniques in
Interventional Cardiology: Drug-Eluting Stents.”
8. Cardiology for the Primary Care Physician, Colorado Springs, CO, November 9, 2002:
“Enhanced External Counterpulsation.”
9. American Heart Association 75th Scientific Sessions, Chicago, IL, November 16, 2002:
“Augmentation of Intracoronary Pressure and Left Ventricular Systolic Unloading During
Enhanced External Counterpulsation.” American Heart Association’s Scientific Sessions,
Samuel A. Levine Young Clinical Investigator Award Finalist [oral abstract presentation].
August 16, 2013 36
10. University HealthSystem Consortium (UHC) Technology Assessment Symposium: Drug-
Eluting Stents, Scottsdale, PH, January 22, 2003: “Impact of Drug-Eluting Stents on
Bypass Surgery.”
11. University of Utah Cardiology Fellow Conference, Salt Lake City, UT, April 9, 2003:
“Hemodynamic Effects of Enhanced External Counterpulsation.”
12. Salinas Medical Center Cardiac Catheterization Laboratory Conference, Salinas, CA, June
6, 2003: “Enhanced External Counterpulsation (EECP).”
13. Webcast Facilitator, University of Florida, August 5, 2003; September 2, 2003; September
9, 2003: “Innovations in Angina Therapy: A Focus on Cardiac Metabolism and Metabolic
Modulation.”
14. 27th
Annual Cardiology Update 2003, Carmel, CA, October 3, 2003: “Novel
Pharmacologic and Non-Pharmacologic Strategies for the Management of Refractory
Angina.”
15. Panelist, Intervention 2004: A National Cardiovascular Symposium, Santa Clara, CA, June
5, 2004: “Symposium on Economic, Regulatory and Legal Issues Surrounding Drug
Eluting Stents.”
16. EECP Symposium, Seattle, WA, September 1, 2004: “EECP for Refractory Angina and
Heart Failure.”
17. American Heart Association’s Scientific Sessions, New Orleans, LA, November 9, 2004:
“Nesiritide acutely increases pulmonary and systemic levels of nitric oxide and cGMP in
pulmonary hypertension patients.”
18. American College of Cardiology Annual Scientific Session, Orlando, FL, March 8, 2005:
“Discussant at the Late-Breaking Clinical Trials: Mechanisms and New Therapeutic
Approaches for the Prospective Evaluation of EECP in Congestive Heart Failure: The
PEECH Trial.”
19. Panelist, Intervention 2005: The Next Generation Interventionalist Symposium, Las Vegas,
NV, June 5, 2005.
20. American Heart Association Scientific Session, Chicago, IL, November 13, 2006, Plenary
Session on Cardioembolic Disease: Identification and Management: “Percutaneous Device
Management of Cardioembolic Disease.”
21. Society for Cardiovascular Angiography and Interventions (SCAI) 32nd
Annual Scientific
Sessions, Las Vegas, NV, May 6, 2009: Judkins Symposium: Echo in the Cath Lab: “Echo
is Bologna, Fluoro is All You Need.”
22. Transcatheter Cardiovascular Therapeutics, San Francisco, CA, November 10, 2011:
“Panel Discussant on Tough Calls in the Cath Lab: Are You Up to the Challenge?
Demystifying Structural Heart Disease Hemodynamics.”
23. American College of Cardiology Scientific Session, San Francisco, CA, March 11, 2013:
Controversies in STEMI Management: Should Thrombectomy be Used Routinely?”
Regional Invited Presentations
August 16, 2013 37
1. UCSF Science Chats, February 27, 1992: “Autoimmunity in Type I Diabetes.”
2. UCSF, Dean’s Prize in Student Research, April 1, 1992: “Autoimmunity and Tolerance in
Type I Diabetes Mellitus: Can Tolerance to GAD Be Broken in Healthy Animals?”
3. UCSF, Non-Invasive Cardiology Conference, June 27, 1997: “Cardiovascular
Manifestations of AIDS.”
4. Mt. Zion/UCSF Heart Reversal Program, July 30, 1998: “Refractory Angina: Novel
Options.”
5. Mt. Zion/UCSF Heart Reversal Program, April 15, 1999: “Refractory Angina: Update.”
6. Cardiovascular Nursing Symposium: Looking Forward, Redwood City, CA, October 8,
1999: “Use of Angiogenesis and Growth Hormones.”
7. American Heart Association John S. Sampson 69th Annual Physician’s Symposium on
Cardiovascular Diseases and Stroke, San Francisco, CA, October 15, 1999: “New
Therapies for Coronary Artery Disease.”
8. Mt. Zion/UCSF Heart Reversal Program, October 28, 1999: “Refractory Angina: Update.”
9. VA Medical Center Research Conference, San Francisco, CA, March 28, 2000:
“Microvascular Dysfunction in Acute Myocardial Infarction.”
10. 29th Annual Advances in Internal Medicine, San Francisco, CA, May 21, 2001: “Advances
in Understanding and Treatment of Acute Coronary Syndromes.”
11. 14th Annual Critical Care Cardiology American College of Cardiology Meeting, San
Francisco, CA, August 17, 2001: “ST-Elevation Acute Myocardial Infarction:
Thrombolysis or PTCA.”
12. 21st Annual Madera Cardiology Symposium, Madera, CA, September 19, 2001: “Current
Indications for PCI (Percutaneous Coronary Interventions) in Acute Coronary Syndromes:
Subsets Most Likely to Benefit;” and “Primary Angioplasty in AMI (Acute Myocardial
Infarction): To Stent or Not to Stent.”
13. Society of Critical Care Medicine Update, San Francisco, CA, October 10, 2001:
“Myocardial Ischemia and Infarction.”
14. Advances in Geriatric Cardiology Symposium, San Francisco, CA, November 30, 2001:
“Taking My Elderly Patient to the Cath Lab: What are the Outcomes?”
15. 15th
Annual Symposium on Cardiac Interventions for Nurses and Technologists, Redwood
City, CA, December 6, 2002: “The Latest Advances in Interventional Cardiology.”
16. Regional Cardiology Meeting, Redding, CA, January 30, 2002: “Enhanced External
Counterpulsation.”
17. Regional Cardiology Meeting, Lancaster, CA, February 27, 2002: “Enhanced External
Counterpulsation.”
18. First Annual Medical Education Day, UCSF School of Medicine, San Francisco, CA, April
22, 2002: “The Web-Based Cardiology Multimedia Library.”
19. Napa Cardiology Community, Yountville, CA, June 3, 2002: “Enhanced External
Counterpulsation.”
August 16, 2013 38
20. 15th
Annual Critical Care Cardiology Meeting, San Francisco, August 10, 2002:
“Cardiogenic Shock in the Thrombolytic Era: How Should We Manage?”
21. Los Angeles Cardiology Community, Los Angeles, CA, October 23, 2002: “Enhanced
External Counterpulsation.”
22. Hoag Hospital Cardiac Catheterization Conference, January 15, 2003, Newport Beach, CA:
“Enhanced External Counterpulsation.”
23. UCSF, Critical Care Cardiology, San Francisco, CA, August 14, 2003: “ST-Elevation
Myocardial Infarction: What is the Best Reperfusion Strategy?”
24. UCSF, Critical Care Cardiology, San Francisco, CA, August 19, 2004: “Cardiogenic
Shock.”
25. UCSF, Cardiology Update, Carmel, CA, October 1, 2004: “Advances in Stent Therapy in
Ischemic Heart Disease.”
26. UCSF, Cardiology Update, Carmel, CA, October 1, 2004: “Equalization of Diastolic
Pressures: What is the Diagnosis?”
27. UCSF, Advances in Heart Failure, San Francisco, CA, December 10, 2004: “Challenging
Cases.”
28. UCSF, Critical Care Medicine & Trauma, San Francisco, CA, June 9, 2005: “Acute
Coronary Syndromes.”
29. UCSF, Medical Center & CV Therapeutics Enhanced External Counterpulsation (EECP)
Tutorial, San Francisco, CA, October 11, 2005: “Mechanisms of EECP’s Benefit.”
30. UCSF, Osher Lifelong Learning Institute, Heart to Heart: Understanding the
Cardiovascular System in Health and Disease Series, November 2, 2005: “Treatment of
Atherosclerotic Heart Disease: Drugs, Stents, or Surgery?”
31. UCSF, Problem Solving in Cardiology: Case Review with Experts, San Francisco, CA,
August 18, 2005: “Acute Coronary Syndromes Management Update.”
32. University of Utah, Cardiovascular Medicine for the Primary Care Provider, Salt Lake
City, UT, September 30, 2006: “Treatment of Atherosclerotic Heart Disease: Drugs, Stents,
or Surgery?”
33. University of Utah, Clinical Cardiology Conference, Salt Lake City, UT, April 16, 2007:
“Antiplatelet Therapy for DES Patients Undergoing Non-Cardiac Surgery.”
34. University of Utah, Advances in Internal Medicine, Park City, UT, February 4, 2009:
“Stable Coronary Artery Disease: Who Needs an Invasive Intervention?” and “Clinical
Cases in Cardiology.”
35. University of Utah, PanVascular Summit, Park City, UT, February 28, 2009: “Complex
PFO Closure.”
36. University of Utah, Madsen Health Clinic, November 10, 2009: “Patent Foramen Ovale
Closure for Stroke and Migraine.”
37. University of Utah, PanVascular Summit, Midway, UT, February 20, 2010: “PFO Closure
for Stroke: How Good is the Evidence?”
August 16, 2013 39
38. American College of Cardiology I2 Summit Scientific Sessions, March 16, 2010:
“Hemodynamics and Clinical Conundrums: Murmur and Dyspnea Case Study.”
39. Western Regional Thrombosis Symposium, University of Utah, May 7, 2010: “Patent
Foramen Ovale: Mechanism of Stroke or Incidental Finding?”
40. Eureka Medical Community, Eureka, CA, January 18, 2011: “Patent Foramen Ovale in
Stroke and Migraine: To Close or Not To Close.”
Grand Rounds Presentations
1. UCSF, Cardiology Grand Rounds, with Hal Barron, June 18, 1997: “Outcomes Research
in Patients with Acute Myocardial Infarction: The First 300,000 Patients.”
2. UCSF, Cardiology Grand Rounds, November 21, 2001: “Update on Immediate
Reperfusion Therapy for Acute Myocardial Infarction.”
3. UCSF, Cardiology Grand Rounds, January 8, 2003: “Update on Enhanced External
Counterpulsation.”
4. Dr. Tsagaris Lecture, Medical Grand Rounds, University of Utah, Salt Lake City, UT,
April 10, 2003: “Enhanced External Counterpulsation (EECP).”
5. University of Virginia, Cardiology Grand Rounds, Charlottesville, VA, February 24, 2004:
“Enhanced External Counterpulsation for Refractory Angina and Heart Failure.”
6. Beijing Tongren Hospital Cardiology, Grand Rounds, Beijing, China, April 28, 2004:
“Current Status of Stem Cell Transplantation for Ischemic Heart Disease.”
7. Grossmont Medical Center Cardiology, Grand Rounds, La Mesa, CA, September 15, 2004:
“EECP for Refractory Angina and Heart Failure.”
8. California Pacific Medical Center Cardiology, Grand Rounds, November 24, 2004:
“Refractory Angina: Novel Options.”
9. UCSF, Cardiology Grand Rounds, June 8, 2005: “Computerized Heart Sound Detection:
Resurrecting Phonocardiography.”
10. San Francisco General Hospital Medicine, Grand Rounds, August 23, 2005:
“Computerized Heart Sound Detection: Resurrecting Phonocardiography.”
11. UCSF, Medicine Grand Rounds, August 25, 2005: “Computerized Heart Sound Detection:
Resurrecting Phonocardiography.”
12. Methodist Hospital Grand Rounds, St. Louis Park, MN, September 6, 2005: “EECP for
Refractory Angina and Heart Failure.”
13. San Francisco Veterans Administration Medicine Grand Rounds, September 27, 2005:
“Computerized Heart Sound Detection: Resurrecting Phonocardiography.”
14. University of Utah, Cardiology Grand Rounds, December 15, 2005: “Heart Sounds and
Hemodynamics.”
15. University of Utah, Medicine Grand Rounds, Salt Lake City, UT, December 7, 2006:
“Resurrecting the Third and Fourth Heart Sounds.”
August 16, 2013 40
16. University of Utah, Cardiology Grand Rounds, October 18, 2007: “DES Insights from
RCTs and Registries: How to Avoid Becoming a Wall Street Journal Walkover.”
17. University of Utah, Anesthesia/Surgery Grand Rounds, November 21, 2007: “Antiplatelet
Therapy for DES Patients Undergoing Non-Cardiac Surgery.”
18. University of Utah, Neurology Grand Rounds, February 6, 2008: “Update on PFO
Closure.”
19. University of Utah, Cardiovascular Service Line Grand Rounds, March 3, 2008:
“Evidence-Based versus Contemporary Patient Selection for PFO Closure.
20. University of Utah, Cardiology Grand Rounds, Salt Lake City, UT, March 12, 2009:
“Interatrial Shunt and Stroke: Single- and Multi-Center Studies.”
21. University of Chicago, Cardiology Grand Rounds, Chicago, IL, May 14, 2010: “Third and
Fourth Heart Sounds.”
22. Mad River Community Hospital, Medicine Grand Rounds, Arcata, CA, January 20, 2011:
“Patent Foramen Ovale in Stroke and Migraine: To Close or Not To Close.”
23. St. Joseph Hospital, Medicine Grand Rounds, Eureka, CA, January 20, 2011: “Patent
Foramen Ovale in Stroke and Migraine: To Close or Not To Close.”
Industry Presentations 1. Genentech, Inc., South San Francisco, CA, May 5, 2000: “Acute Myocardial Infarction.”
2. Vasomedical Sales Force Training Forum, Orlando, FL, January 19, 2003: “Hemodynamic
Effects of Enhanced External Counterpulsation.”
3. Philips First Annual Cardiovascular CT Symposium, Miami Beach, FL, January 25, 2003:
“Non-Invasive Therapy for CAD: Enhanced External Counterpulsation (EECP).”
4. 2nd
Annual Investigator Initiated Scios Meeting, December 13, 2003, Dallas, Texas:
“Effects of Nesiritide on Coronary and Pulmonary Vascular Hemodynamics.”
5. CV Therapeutics Managed Care Advisory Meeting, San Francisco, CA, March 31, 2004:
“Disease State and Angina Update: Current Treatments and New Opportunities for the
Patient.”
6. UCSF Medical Center & CV Therapeutics Enhanced External Counterpulsation (EECP)
Tutorial, San Francisco, CA, October 11, 2005: “Mechanisms of EECP’s Benefit.”
7. Daiichi Sankyo and Eli Lilly; Durango, CO, November 2, 2009; Logan Regional Medical
Center, Logan, Utah, November 9, 2009; Carson City, NV, November 10, 2009; Ogden
Regional Medical Center, Ogden, Utah, November 23, 2009; Idaho Falls, ID, December
16, 2009; Mountain View Hospital, Payson, UT, December 17, 2009; February 8, 2010,
Boise, ID: “Effient (Prasugrel): Antiplatelet Therapy to Help Reduce Cardiovascular
Events in Patients with Acute Coronary Syndrome (ACS) Managed with Percutaneous
Coronary Intervention (PCI).”
Professional Meetings Chaired
August 16, 2013 41
1. International External Counterpulsation (ECP) Symposium. Executive Chairman.
Guangzhou, China, May 13-14, 2006.
2. PanVascular Summit. Chairman. Park City, UT, February 26-28, 2009; Midway, UT,
February 19-20, 2010. Organized a CME-accredited meeting with 81 registered
participants and 26 faculty, including live case demonstrations from the University of Utah
Cardiac Catheterization Laboratory.
3. EECP at the Great Wall International Congress of Cardiology 2009 and the 2nd
International EECP Symposium. Executive Chairman. Beijing, China, October 9, 2009.
